<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27754318</article-id>
<article-id pub-id-type="pmc">5085743</article-id>
<article-id pub-id-type="doi">10.3390/ijms17101711</article-id>
<article-id pub-id-type="publisher-id">ijms-17-01711</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Selection of Suitable Reference Genes for Analysis of Salivary Transcriptome in Non-Syndromic Autistic Male Children</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Panahi</surname>
<given-names>Yasin</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-17-01711">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salasar Moghaddam</surname>
<given-names>Fahimeh</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-17-01711">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghasemi</surname>
<given-names>Zahra</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-17-01711">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hadi Jafari</surname>
<given-names>Mandana</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-17-01711">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shervin Badv</surname>
<given-names>Reza</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-17-01711">3</xref>
<xref ref-type="aff" rid="af4-ijms-17-01711">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eskandari</surname>
<given-names>Mohamad Reza</given-names>
</name>
<xref ref-type="aff" rid="af5-ijms-17-01711">5</xref>
<xref ref-type="aff" rid="af6-ijms-17-01711">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pedram</surname>
<given-names>Mehrdad</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-17-01711">1</xref>
<xref ref-type="corresp" rid="c1-ijms-17-01711">*</xref>
</contrib>
</contrib-group>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Bustin</surname>
<given-names>Stephen A.</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<aff id="af1-ijms-17-01711"><label>1</label>Department of Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences (ZUMS), Zanjan 45139-56111, Iran; <email>panahi.y@zums.ac.ir</email> (Y.P.); <email>mandana.hj@gmail.com</email> (M.H.J.)</aff>
<aff id="af2-ijms-17-01711"><label>2</label>Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences (ZUMS), Zanjan 45139-56111, Iran; <email>f.moghaddam91@gmail.com</email> (F.S.M.); <email>zahra.ghasemi77@gmail.com</email> (Z.G.)</aff>
<aff id="af3-ijms-17-01711"><label>3</label>Department of Pediatric Neurology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran 14176-13151, Iran; <email>badv@sina.tums.ac.ir</email></aff>
<aff id="af4-ijms-17-01711"><label>4</label>Children’s Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences (TUMS), Tehran 14176-13151, Iran</aff>
<aff id="af5-ijms-17-01711"><label>5</label>Metrowest CNS Research Center, Natick, MA 01760, USA; <email>dr.eskandari@gmail.com</email></aff>
<aff id="af6-ijms-17-01711"><label>6</label>Department of Psychiatry, School of Medicine, Zanjan University of Medical Sciences (ZUMS), Zanjan 45139-56111, Iran</aff>
<author-notes>
<corresp id="c1-ijms-17-01711"><label>*</label>Correspondence: <email>mpedram@zums.ac.ir</email>; Tel./Fax: +98-24-3344-9553</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2016</year>
</pub-date>
<volume>17</volume>
<issue>10</issue>
<elocation-id>1711</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
<copyright-year>2016</copyright-year>
<license>
<license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Childhood autism is a severe form of complex genetically heterogeneous and behaviorally defined set of neurodevelopmental diseases, collectively termed as autism spectrum disorders (ASD). Reverse transcriptase quantitative real-time PCR (RT-qPCR) is a highly sensitive technique for transcriptome analysis, and it has been frequently used in ASD gene expression studies. However, normalization to stably expressed reference gene(s) is necessary to validate any alteration reported at the mRNA level for target genes. The main goal of the present study was to find the most stable reference genes in the salivary transcriptome for RT-qPCR analysis in non-syndromic male childhood autism. Saliva samples were obtained from nine drug naïve non-syndromic male children with autism and also sex-, age-, and location-matched healthy controls using the RNA-stabilizer kit from DNA Genotek. A systematic two-phased measurement of whole saliva mRNA levels for eight common housekeeping genes (HKGs) was carried out by RT-qPCR, and the stability of expression for each candidate gene was analyzed using two specialized algorithms, geNorm and NormFinder, in parallel. Our analysis shows that while the frequently used HKG <italic>ACTB</italic> is not a suitable reference gene, the combination of <italic>GAPDH</italic> and <italic>YWHAZ</italic> could be recommended for normalization of RT-qPCR analysis of salivary transcriptome in non-syndromic autistic male children.</p>
</abstract>
<kwd-group>
<kwd>childhood autism</kwd>
<kwd>non-syndromic</kwd>
<kwd>transcriptome</kwd>
<kwd>saliva</kwd>
<kwd>reverse transcriptase quantitative real-time PCR (RT-qPCR)</kwd>
<kwd>housekeeping genes (HKGs)</kwd>
<kwd>reference gene</kwd>
<kwd>stability of expression</kwd>
<kwd>geNorm</kwd>
<kwd>NormFinder</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-17-01711">
<title>1. Introduction</title>
<p>Autism spectrum disorders (ASD) are serious, lifelong pervasive neurodevelopmental disorders characterized by impairments in reciprocal social interaction, including verbal and non-verbal communication, and also repetitive stereotyped behavioral patterns [<xref ref-type="bibr" rid="B1-ijms-17-01711">1</xref>]. Childhood autism, which is the most severe form of ASD with an early life onset, is typically diagnosed between the ages of 2 and 3 years [<xref ref-type="bibr" rid="B2-ijms-17-01711">2</xref>] and a male to female ratio of about 4:1 [<xref ref-type="bibr" rid="B3-ijms-17-01711">3</xref>]. There is no doubt that genetic components play a key role in the pathogenesis of ASD with a high heritability index. However, the genes that have been associated with ASD only relate to only a small portion of the cases [<xref ref-type="bibr" rid="B4-ijms-17-01711">4</xref>].</p>
<p>Due to the wide range of genetic heterogeneity reported in ASD, it is quite possible that different causes and various underlying molecular mechanisms may lead to a common set of changes in the brain resulting in a similar behavioral profile [<xref ref-type="bibr" rid="B5-ijms-17-01711">5</xref>,<xref ref-type="bibr" rid="B6-ijms-17-01711">6</xref>]. Nonetheless, analysis of the transcriptome, as an intermediate phenotype, still could provide valuable insights for investigation of such complex cases. Careful comparison of the gene expression profiles in autistic patients with normal subjects could provide important clues for the development of autism and also the molecular mechanisms and crossroads involved. Reverse transcriptase quantitative real-time PCR (RT-qPCR) is a highly sensitive technique for investigation of gene expression profile, and it is also used for confirmation of microarray results [<xref ref-type="bibr" rid="B7-ijms-17-01711">7</xref>,<xref ref-type="bibr" rid="B8-ijms-17-01711">8</xref>]. However, accurate analysis of gene expression with RT-qPCR requires proper normalization to stably expressed internal control or reference gene(s) [<xref ref-type="bibr" rid="B9-ijms-17-01711">9</xref>]. An important caveat to consider for selection of reference genes, which are typically selected from housekeeping genes (HKGs), is that expression of HKGs could vary significantly under different biological conditions including disease states, age, sex, drug treatment. Furthermore, the stability of expression for a particular HKG could also be dependent upon the tissue type/source used for RNA isolation and experimental design [<xref ref-type="bibr" rid="B10-ijms-17-01711">10</xref>,<xref ref-type="bibr" rid="B11-ijms-17-01711">11</xref>]. Therefore, selection of appropriate reference genes for a complex neurodevelopmental disorder such as autism requires very careful design and planning.</p>
<p>A review of the literature shows that no single gene or particular set of genes has been used consistently as reference in gene expression studies in ASD, using either the brain or blood as the main RNA source (<xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>) [<xref ref-type="bibr" rid="B12-ijms-17-01711">12</xref>,<xref ref-type="bibr" rid="B13-ijms-17-01711">13</xref>,<xref ref-type="bibr" rid="B14-ijms-17-01711">14</xref>,<xref ref-type="bibr" rid="B15-ijms-17-01711">15</xref>,<xref ref-type="bibr" rid="B16-ijms-17-01711">16</xref>,<xref ref-type="bibr" rid="B17-ijms-17-01711">17</xref>,<xref ref-type="bibr" rid="B18-ijms-17-01711">18</xref>,<xref ref-type="bibr" rid="B19-ijms-17-01711">19</xref>,<xref ref-type="bibr" rid="B20-ijms-17-01711">20</xref>,<xref ref-type="bibr" rid="B21-ijms-17-01711">21</xref>,<xref ref-type="bibr" rid="B22-ijms-17-01711">22</xref>,<xref ref-type="bibr" rid="B23-ijms-17-01711">23</xref>,<xref ref-type="bibr" rid="B24-ijms-17-01711">24</xref>,<xref ref-type="bibr" rid="B25-ijms-17-01711">25</xref>,<xref ref-type="bibr" rid="B26-ijms-17-01711">26</xref>,<xref ref-type="bibr" rid="B27-ijms-17-01711">27</xref>,<xref ref-type="bibr" rid="B28-ijms-17-01711">28</xref>,<xref ref-type="bibr" rid="B29-ijms-17-01711">29</xref>,<xref ref-type="bibr" rid="B30-ijms-17-01711">30</xref>,<xref ref-type="bibr" rid="B31-ijms-17-01711">31</xref>,<xref ref-type="bibr" rid="B32-ijms-17-01711">32</xref>,<xref ref-type="bibr" rid="B33-ijms-17-01711">33</xref>,<xref ref-type="bibr" rid="B34-ijms-17-01711">34</xref>]. Surprisingly, as we will further outline in the discussion, almost none of these studies have embarked on a systematic validation of the reference gene(s) prior to the start of the experiment. In the present study, we: (1) propose using saliva as a readily available biofluid and an alternative noninvasive sampling source for transcriptome analysis in childhood autism; and (2) provide a systematic evaluation for the expression levels of eight commonly used HKGs in whole saliva samples in drug naïve non-syndromic autistic male children, as a highly important yet defined subset of ASD patients, and healthy sex-, age-, and location-matched controls.</p>
</sec>
<sec id="sec2-ijms-17-01711">
<title>2. Results</title>
<sec id="sec2dot1-ijms-17-01711">
<title>2.1. Selection of Candidate Reference Genes and Initial Screening</title>
<p>The present study was prompted by an earlier experiment, during which saliva samples were obtained from five lab members and β-actin gene (<italic>ACTB</italic>) mRNA levels were measured for RNA quality analysis. It should be noted that <italic>ACTB</italic> has been used previously by other investigators for RNA quality and transcriptome analysis by RT-qPCR in saliva [<xref ref-type="bibr" rid="B35-ijms-17-01711">35</xref>,<xref ref-type="bibr" rid="B36-ijms-17-01711">36</xref>,<xref ref-type="bibr" rid="B37-ijms-17-01711">37</xref>,<xref ref-type="bibr" rid="B38-ijms-17-01711">38</xref>], and that it also has been used as a common internal control for gene expression studies in ASD (<xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>). Interestingly, while <italic>ACTB</italic>
<italic>Cq</italic> values were stable in the salivary transcriptome derived from the lab members (i.e., adults), the <italic>Cq</italic> values varied when examined in five samples (one autistic and four healthy control subjects) taken from children (<xref ref-type="app" rid="app1-ijms-17-01711">Table S1</xref>).</p>
<p>There were limited amounts of saliva samples taken from our clinical groups, collected within a two-year period, available for future studies. Thus, in order to systematically evaluate potential reference genes for normalization of gene expression levels in whole saliva collected from patients with non-syndromic childhood autism and the healthy controls, a two-phase analysis was performed. In the first phase, for initial screening, mRNAs levels of eight candidate HKGs (<xref ref-type="table" rid="ijms-17-01711-t002">Table 2</xref>) were examined by RT-qPCR using equal amounts of RNA templates extracted from four saliva samples: two samples taken from autistic patients, and two from healthy controls. The RT-qPCR procedures were designed and performed in line with the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines [<xref ref-type="bibr" rid="B10-ijms-17-01711">10</xref>]. The mean <italic>Cq</italic> values ± SD (<italic>n</italic> = 2–4) for each candidate gene are presented on <xref ref-type="table" rid="ijms-17-01711-t003">Table 3</xref> (see <xref ref-type="app" rid="app1-ijms-17-01711">Table S2</xref> for detailed individual average <italic>Cq</italic> values of replicate qPCR reactions ± SD).</p>
<p>To analyze the stability of expression for the candidate HKGs, the <italic>Cq</italic> values of each data set were exported to a Microsoft Office Excel sheet and then imported into the geNorm (qbasePLUS software v2.2, Biogazelle, Ghent, Belgium) and also NormFinder (Molecular Diagnostic Labrotory, Department of Clinical Biochemistry Molecular Medicine, Aarhus University Hospital, Skejby, Aarhus, Denmark) software. GeNorm, which is a strong algorithm for small sample sizes and also the most widely used algorithm to determine the most stable reference gene, calculates an expression normalization factor for each sample set by geometric averaging of a number of user-defined candidate reference genes. For each candidate gene, the geNorm algorithm determines an internal control stability measure (M), which is defined as the average pairwise variation of a particular gene compared with all other test genes. The lowest M value indicates the most stable gene [<xref ref-type="bibr" rid="B40-ijms-17-01711">40</xref>]. By contrast, NormFinder that is also a visual basic application for Microsoft Excel focuses on the expression variation of each gene with the least intra- and inter-group values in a model-based approach. In addition to giving a direct measure for the estimated expression variation, the NormFinder algorithm evaluates the systematic error introduced when using the HKG of interest as internal control [<xref ref-type="bibr" rid="B41-ijms-17-01711">41</xref>].</p>
<p>According to the geNorm algorithm, the M values below the cut-off value of 1.5 (the recommended threshold) are acceptable in the selection of internal controls for normalization in RT-qPCR [<xref ref-type="bibr" rid="B40-ijms-17-01711">40</xref>]. As it can be seen from <xref ref-type="fig" rid="ijms-17-01711-f001">Figure 1</xref>A, the data output from geNorm for the first phase of evaluation indicated that glyceraldehyde-3-phosphate dehydrogenase gene (<italic>GAPDH</italic>) was the best HKG in our panel of candidate reference genes followed by succinate dehydrogenase complex subunit A, flavoprotein (<italic>SDHA</italic>), tyrosine 3 monooxygenase activation protein, zeta polypeptide (<italic>YWHAZ</italic>), and ubiquitin C (<italic>UBC</italic>). <italic>ACTB</italic>, a traditionally common reference gene in normalization of RT-qPCR data in ASD studies (<xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>) and salivary transcriptome analysis [<xref ref-type="bibr" rid="B35-ijms-17-01711">35</xref>,<xref ref-type="bibr" rid="B37-ijms-17-01711">37</xref>,<xref ref-type="bibr" rid="B38-ijms-17-01711">38</xref>], was ranked among the least stable genes. The number of reference genes needed for optimal normalization was determined by geNorm based on the average pairwise variation (V<italic>n</italic>/<italic>n</italic> + 1) below the recommended cut-off point value of 0.15. At this phase, the geNorm output indicated that the combination of the best three reference genes would be sufficient for normalization of RT-qPCR data (<xref ref-type="app" rid="app1-ijms-17-01711">Figure S1</xref>).</p>
<p>The ranking of the best candidate genes by NormFinder algorithm in phase I was somewhat similar to the geNorm output. <italic>GAPDH</italic>, <italic>YWHAZ</italic>, and <italic>UBC</italic> were ranked as the best candidates, respectively (<xref ref-type="fig" rid="ijms-17-01711-f001">Figure 1</xref>B). However, <italic>SDHA</italic> was demoted to the 6th rank, while <italic>ACTB</italic> was promoted two steps from low to the intermediate ranking. It should be noted that, in phase I, the clinical identifier value was not included in the NormFinder analysis due to the small number of samples, and thus analysis was performed as a single clinical group. In both algorithms, two of the candidate genes, encoding for ribosomal protein L13a (RPL13A) and transferrin receptor (TFRC), were ranked as the least stable HKGs based on their high variation of relative expression values.</p>
</sec>
<sec id="sec2dot2-ijms-17-01711">
<title>2.2. Expression Profiling and Validation of Candidate Reference Genes</title>
<p>Three of the candidate HKGs that had the best scores in phase I based on both geNorm and NormFinder algorithms (<italic>GAPDH</italic>, <italic>YWHAZ</italic>, and <italic>UBC</italic>) were selected for the second phase of analysis. Despite its low-intermediate ranking in phase I, <italic>ACTB</italic> was also taken for further analysis because of its common usage as an internal control HKG in saliva [<xref ref-type="bibr" rid="B35-ijms-17-01711">35</xref>,<xref ref-type="bibr" rid="B38-ijms-17-01711">38</xref>,<xref ref-type="bibr" rid="B42-ijms-17-01711">42</xref>] and ASD studies (<xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>). In this phase, the expression levels of the final four candidate HKGs were examined in saliva samples from a panel of nine autistic and healthy boys (average age: 47.6 ± 21.9 vs. 41.2 ± 26.7 months, respectively). The amplification efficiency for each gene and linear regression coefficient (R2) values were calculated by performing standard curves (<xref ref-type="table" rid="ijms-17-01711-t004">Table 4</xref>). The scatter plot representations of the <italic>Cq</italic> values recorded for the final four candidate HKGs in the autistic and healthy clinical groups are shown in <xref ref-type="fig" rid="ijms-17-01711-f002">Figure 2</xref> (<xref ref-type="app" rid="app1-ijms-17-01711">Table S3</xref> for detailed average <italic>Cq</italic> values for replicate qPCR reactions ±SD).</p>
<p>Noticeably, geNorm once again ranked <italic>GAPDH</italic> as the most stable HKG, and it ranked <italic>ACTB</italic> as the least stable gene (<italic>M</italic> values: 1.29 vs. 1.84, respectively). However, after the pairwise analysis, the combination of <italic>GAPDH</italic> and <italic>YWHAZ</italic> was selected as the best pair with an <italic>M</italic>-value of 1.02, followed by <italic>UBC</italic> and <italic>ACTB</italic> with <italic>M</italic>-values of 1.45 vs. 1.67, respectively (<xref ref-type="fig" rid="ijms-17-01711-f003">Figure 3</xref>A). An optimal number for reference genes was not determined by geNorm algorithm because the <italic>V</italic>-value was higher than recommended threshold (0.15). Similar to the geNorm analysis, NormFinder evaluated <italic>GAPDH</italic> as the most stable HKG, followed by <italic>YWHAZ</italic>, <italic>UBC</italic>, and <italic>ACTB</italic> (Stability values: 0.35, 0.60, 1.18, and 1.40, respectively). However, when the clinical subgroups were included in the analysis, the <italic>GAPDH</italic> and <italic>YWHAZ</italic> set was recommended as the best combination of two genes by NormFinder, followed by <italic>UBC</italic> (ranked third) and <italic>ACTB</italic>, ranked as the least stable gene once again (<xref ref-type="fig" rid="ijms-17-01711-f003">Figure 3</xref>B).</p>
</sec>
<sec id="sec2dot3-ijms-17-01711">
<title>2.3. Relative Expression Levels of Candidate Reference Genes in Autistic vs. Healthy Subjects</title>
<p>Using <italic>GAPDH</italic>, the most stable HKG ranked by both geNorm and NormFinder algorithms, as reference, and employing an improved 2<sup>−Δ<italic>C</italic>t</sup> method [<xref ref-type="bibr" rid="B43-ijms-17-01711">43</xref>] (by taking into account the amplification efficiencies), the relative expression levels of other three genes were compared in the autistic children vs. the control group (<xref ref-type="fig" rid="ijms-17-01711-f004">Figure 4</xref>A). The results demonstrate that although <italic>ACTB</italic> shows a higher degree of variation compared with <italic>UBC</italic> and <italic>YWHAZ</italic> (<italic>p</italic>-values: 0.26, 0.45 and 0.82, respectively), as expected, there are no significant differences in the expression levels of any of these HKGs between the two clinical groups. By contrast, when <italic>ACTB</italic>, which was ranked as the least stable, was used as reference, the expression levels of <italic>GAPDH</italic>, <italic>UBC</italic>, and <italic>YWHAZ</italic> did not follow a normal distribution pattern, and in particular, the <italic>UBC</italic> expression levels and median values were significantly different (<italic>p</italic> = 0.03) between the autistic and control groups (<xref ref-type="fig" rid="ijms-17-01711-f004">Figure 4</xref>B).</p>
<p>The above observations are in support of the ranking validity of the candidate reference genes by geNorm and NormFinder algorithms, and they clearly demonstrate how selection of an inappropriate HKG as reference can bias interpretation of RT-qPCR data. Interestingly, examination of the <italic>Cq</italic> values obtained for the candidate HKGs using a third statistical algorithm applet, called BestKeeper [<xref ref-type="bibr" rid="B44-ijms-17-01711">44</xref>], produced a similar ranking for the candidate reference genes, in particular for Phase II (<xref ref-type="app" rid="app1-ijms-17-01711">Table S4</xref>). It should be noted that the BestKeeper algorithm works by calculating the SD for each gene of interest and Pearson’s coefficient of correlation for each pair of the candidate genes. Thus, it would be best suited for our Phase II analysis, as BestKeeper cannot provide significant <italic>p</italic>-values for small sample sets (<xref ref-type="app" rid="app1-ijms-17-01711">Table S4A,B</xref>). Nonetheless, based on the intra-variations for each candidate gene, the Phase I ranking by BestKeeper is not that far off from those produced by geNorm and NormFinder.</p>
</sec>
</sec>
<sec id="sec3-ijms-17-01711">
<title>3. Discussion</title>
<p>To our knowledge, this is the first systematic evaluation of HKGs as reference for RT-qPCR analysis of salivary transcriptome in patients with autism reported so far. ASD encompass a heterogeneous set of complex and pervasive behaviorally-defined neurodevelopmental disorders, which brings up the possibility of different causes leading to similar brain deficits and behavioral patterns. In fact, there is a strong consensus on the involvement of various genetic and environmental components in the etiology of ASD [<xref ref-type="bibr" rid="B1-ijms-17-01711">1</xref>,<xref ref-type="bibr" rid="B6-ijms-17-01711">6</xref>]. Nonetheless, because of the high heritability reported in ASD, it should be quite plausible to search for a “common signature” at the level of gene expression profile. Thus, analysis of the transcriptome, as an intermediate phenotype for investigation, could provide insights into the molecular mechanism/s involved [<xref ref-type="bibr" rid="B5-ijms-17-01711">5</xref>]. However, despite enormous number of research and concerted efforts at the international level during the past decade, as evident on <xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>, there is still an incoherent picture of a common gene expression profile signature/s for ASD, and the underlying molecular mechanisms are poorly understood.</p>
<p>A recent highly in depth meta-analysis of ASD gene expression data, taken from 12 independent studies in blood and brain tissues, by Ch’ng et al. conclude that constructing a somewhat consistent transcriptome signature might be possible in the studies using a small number of brain samples. By contrast, the outcomes of the studies using blood cells are highly heterogeneous and rather inconsistent [<xref ref-type="bibr" rid="B5-ijms-17-01711">5</xref>]. As pointed out by the investigators, part of the inconsistency in these studies could be due to the variation in their inclusion and exclusion criteria, which include variations in the scope of the ASD patients studied, differences in gender and age groups, and differences in sampling and experimental procedures. A review of the information presented on <xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref> supports the notion of such variations in different ASD studies. Another important factor to note, however, is the inconsistency in the use of reference genes in different studies, even in cases where the type of tissue/cells used for transcriptome analysis were the same or very similar.</p>
<p>Selection of appropriate reference gene(s) plays an essential part in proper normalization of RT-qPCR assays and comparison of gene expression profiles between different samples and clinical groups. It is also essential that validity and stability of expression for the candidate or intended internal control HKG/s is experimentally examined for particular source/s of RNA, disease status, and experimental design prior to the start of each experiment [<xref ref-type="bibr" rid="B10-ijms-17-01711">10</xref>,<xref ref-type="bibr" rid="B40-ijms-17-01711">40</xref>,<xref ref-type="bibr" rid="B41-ijms-17-01711">41</xref>]. Surprisingly, a careful examination of the ASD gene expression studies listed on <xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>, however, reveals that the HKGs used as internal controls were not systematically evaluated for their stability of expression for the particular tissue/cell type, and biological and experimental conditions. Perhaps, the only one exception on that list is the case report study by Griesi-Oliveira et al. using dental pulp stem cells for their main RNA source. Aside from the fact that the particular female patient in this study suffered from a craniofacial dysmorphism in addition to ASD phenotype, it should be noted that because of the very small and restricted sample size (only one patient and two controls from the same family), validation of the reference genes in this study has a very low power. It is also interesting to note that even with such a small and restricted sample size, when the investigators used the geNorm applet for selection of the reference genes, they ended up with a set of four HKGs in order to generate a normalization factor [<xref ref-type="bibr" rid="B30-ijms-17-01711">30</xref>]. The study by Nardone et al., using postmortem brain tissues, used a set of four HKGs based on a geNorm evaluation of candidate reference genes by a separate group of investigators on suicide subjects [<xref ref-type="bibr" rid="B34-ijms-17-01711">34</xref>,<xref ref-type="bibr" rid="B45-ijms-17-01711">45</xref>]. Finally, the study by Garbett et al., using a small set (six; four male and two female subjects) of postmortem brain tissue samples, selected only one HKG, <italic>ACTB</italic>, for validation of their microarray results based on the previous works by the same lab [<xref ref-type="bibr" rid="B18-ijms-17-01711">18</xref>] on small numbers of postmortem brain samples from schizophrenic and epileptic patients [<xref ref-type="bibr" rid="B46-ijms-17-01711">46</xref>,<xref ref-type="bibr" rid="B47-ijms-17-01711">47</xref>].</p>
<p>An ideal reference gene should maintain a stable mRNA level in all sample groups under different experimental conditions. It might not be possible to find a “universal” reference gene or set of genes in different tissues for various biological and experimental conditions. However, it is quite feasible to find the most appropriate HKGs for normalization of gene expression profiling if one limits the type and number of tissues tested under a well-defined experimental setting [<xref ref-type="bibr" rid="B40-ijms-17-01711">40</xref>,<xref ref-type="bibr" rid="B41-ijms-17-01711">41</xref>]. As mentioned several times already, ASD encompass a heterogeneous and complex set of neurodevelopmental disorders. In the present study, in an effort to limit the number of confounders and heterogeneity, we confined the scope of the ASD subjects to drug naïve non-syndromic autistic male children and age-, and sex-matched healthy children picked from the same neighborhoods as the patients (average ages: 47.6 ± 21.9 vs. 41.2 ± 26.7 months, respectively). Considering the severity of childhood autism and also the high ratio of male children affected, the autistic patients used in this study represent a highly important yet defined subset of ASD patients. We also used saliva as an alternative “noninvasive” sampling source for RNA instead of the blood. As the most available and portable biofluid, saliva contains a wealth of information regarding the physiological states of the body and is a good indicator of the plasma levels of hormones, drugs, immune system, and neurological conditions [<xref ref-type="bibr" rid="B48-ijms-17-01711">48</xref>,<xref ref-type="bibr" rid="B49-ijms-17-01711">49</xref>]. In recent years, saliva has been used a valid source of biomarkers and transcriptome analysis for a number of systemic human diseases including sleep disorder [<xref ref-type="bibr" rid="B38-ijms-17-01711">38</xref>] and breast cancer [<xref ref-type="bibr" rid="B50-ijms-17-01711">50</xref>].</p>
<p>Saliva has also been used as a DNA source for epigenetic analysis in bipolar disorder and schizophrenia [<xref ref-type="bibr" rid="B51-ijms-17-01711">51</xref>], for genetic analysis and investigation of the impact of nutritional intake and environmental toxins in ASD [<xref ref-type="bibr" rid="B52-ijms-17-01711">52</xref>]. Most recently, Frank Middleton and colleagues used the salivary microRNA profiles for identification of children with ASD [<xref ref-type="bibr" rid="B53-ijms-17-01711">53</xref>]. Here, we present the first systematic evaluation of HKGs in the salivary transcriptome to be used for normalization of RT-qPCR data in ASD research. Based on our analysis of gene expression stability using geNorm and NormFinder algorithms in parallel, <italic>GAPDH</italic> was determined as the most stable HKG to be used as an internal control for salivary transcriptome analysis and/or validation of microarray results by RT-qPCR in male childhood autism. By contrast, <italic>ACTB</italic> was evaluated as unsuitable to be used as a reference gene. It should be noted, however, that <italic>GAPDH</italic> does not appear to be stable enough to be used as a single reference gene for normalization of RT-qPCR data in this setting. Both geNorm and Normfinder analyses recommend combination of <italic>GAPDH</italic> and <italic>YWHAZ</italic> as the best option. However, the V value given by the geNorm algorithm in our second phase of study is above the ideal 0.15. A simple interpretation of the results from geNorm’s point of view would entails using all four candidate genes as internal controls. However, considering the high variation of <italic>ACTB</italic> expression, and significantly low levels of <italic>UBC</italic> expression between the autistic and control samples (<xref ref-type="app" rid="app1-ijms-17-01711">Figure S1</xref> and <xref ref-type="fig" rid="ijms-17-01711-f004">Figure 4</xref>), it would not be advisable to add either of them to the <italic>GAPDH</italic> and <italic>YWHAZ</italic> combination.</p>
<p>The poor evaluation of <italic>ACTB</italic> as a reference gene in saliva samples, in a sharp contrast to <italic>GAPDH</italic>, initially came to us as a surprise. However, a careful review of the literature revealed this to be a well-supported outcome by various lines of evidence. While <italic>ACTB</italic> was traditionally used as a reference gene in saliva [<xref ref-type="bibr" rid="B38-ijms-17-01711">38</xref>], even pioneer labs specializing in saliva work have recently switched to using <italic>GAPDH</italic> instead [<xref ref-type="bibr" rid="B50-ijms-17-01711">50</xref>,<xref ref-type="bibr" rid="B54-ijms-17-01711">54</xref>]. In contrast to this notion, in a recent report by Pandit and colleagues on a high-yield RNA-extraction protocol for saliva, the investigators used <italic>ACTB</italic> in combination with the saliva-specific histatin 3 gene (<italic>HTN3</italic>) for validation of the quality and quantity of their isolated RNA samples. They also used <italic>ACTB</italic> alone as their reference HKG for analysis of 2 cell lines and a cohort of cancer patients and controls [<xref ref-type="bibr" rid="B35-ijms-17-01711">35</xref>]. However, a review of the <italic>Cq</italic> values listed for <italic>ACTB</italic> in their <xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>, shows a very high variation in the <italic>Cq</italic> values (18 Cq differences for all samples, and 13 Cq differences within the clinical samples only) for <italic>ACTB</italic>, making it unsuitable to be used as a reference gene. Furthermore, it should be kept in mind that the saliva samples taken in our study were obtained from young children (average age for both groups: 44.4 ± 23.9 months) that are going through a highly significant growth period. A key developmental and cytoskeletal protein coding gene like <italic>ACTB</italic> may not be suited as a reference gene for this age period. In support of this line of reasoning, a recent investigation of HKGs in leukocyte subpopulations from children by Yu and colleagues found that <italic>GAPDH</italic> had the most stable expression in children (five samples: 1, 3, 6, 9, and 12 years old). By contrast, the ACTB protein levels were inconsistent. The investigators reported that <italic>ACTB</italic> mRNA levels were not significantly different across their samples and propose a difference at the level of post-translational regulation. However, there is no mention of the <italic>ACTB</italic>
<italic>Cq</italic> values/variation provided in the article [<xref ref-type="bibr" rid="B55-ijms-17-01711">55</xref>].</p>
<p>In contrast to our findings indicating <italic>ACTB</italic> as an unsuitable internal control for RT-qPCR analysis in childhood autism, the study by Garbett and colleagues gives <italic>ACTB</italic> a high praise as a reference gene for transcriptome analysis in postmortem brain tissue samples from ASD patients [<xref ref-type="bibr" rid="B18-ijms-17-01711">18</xref>]. Aside from the fact that we have used a different source for RNA, a close inspection of the report by Garbett et al. reveals some interesting points. The authors provide several reasons for why they chose <italic>ACTB</italic> as the reference gene for RT-qPCR verification of their microarray results, including that it had been previously established as a stable HKG in the literature (referring to a study by Chen et al. on the primary human skin fibroblasts [<xref ref-type="bibr" rid="B56-ijms-17-01711">56</xref>]); and in two previous studies on human postmortem brain tissues by the same lab, one in subjects with schizophrenia [<xref ref-type="bibr" rid="B46-ijms-17-01711">46</xref>] and one in epilepsy [<xref ref-type="bibr" rid="B47-ijms-17-01711">47</xref>]. Aside from the fact that we have used a different source of RNA in the present study compared with the studies noted above, the reasoning outlined by Garbett et al. for selection of their internal control HKG is not convincing. The fact that <italic>ACTB</italic> has been previously used as an endogenous reference gene in primary human skin fibroblasts (a different tissue type), and that it has been used in the brain tissue samples in schizophrenia and epilepsy (different disease types), are not valid justifications for using <italic>ACTB</italic> as a reference gene in brain tissue samples for ASD studies. Two recent systematic evaluations of HKGs, with both studies including <italic>ACTB</italic> and <italic>GAPDH</italic>, for RT-qPCR in postmortem human brain tissues came up with entirely different sets of reference genes. While Silberberg and colleagues found <italic>TFRC</italic> and <italic>RPLP0</italic> as the most stable reference genes in schizophrenia and bipolar disorders [<xref ref-type="bibr" rid="B57-ijms-17-01711">57</xref>], Penna and colleagues found CYC1 and EIF4A2 as the best reference genes in Alzheimer’s disease [<xref ref-type="bibr" rid="B58-ijms-17-01711">58</xref>]. Finally, it is interesting to note that a review of the reference genes used in ASD studies shows a noticeable shift from <italic>ACTB</italic> to <italic>GAPDH</italic> during the past 15 years (<xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>).</p>
</sec>
<sec id="sec4-ijms-17-01711">
<title>4. Materials and Methods</title>
<sec id="sec4dot1-ijms-17-01711">
<title>4.1. Subjects and Sampling Procedure</title>
<p>Participants recruited to this study included nine drug naïve non-syndromic male children diagnosed with autism (47.6 ± 21.9 months) and nine age-, gender-, and location-matched typically developing healthy controls (41.2 ± 26.7 months). Children with autism were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders fourth edition, Text Revised (DSM-IV-TR) criteria by two qualified clinicians, a child neurologist and a child and adolescent psychiatrist. The diagnosis of autism was confirmed by Autism Diagnostic Interview-Revised (ADI-R), which is a standardized semi-structured diagnostic algorithm for autism based on the definitions set by DSM-IV and International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) [<xref ref-type="bibr" rid="B59-ijms-17-01711">59</xref>,<xref ref-type="bibr" rid="B60-ijms-17-01711">60</xref>]. Exclusion criteria for patients included any other medical disorder and/or diagnosis including significant neurological problems such as depression, epileptic seizures, and genetic syndromes such as tuberous sclerosis, Angelman, and Fragile-X. Sex-matched healthy control children were picked from the same neighborhood locations as the autistic subjects. All healthy controls were screened by the Strengths and Difficulties Questionnaire (SDQ) [<xref ref-type="bibr" rid="B61-ijms-17-01711">61</xref>]. The study was conducted in accordance with the Declaration of Helsinki, and it had the approval of the ZUMS Ethics Committee (ZUMS.REC.1392 97; 13 October 2013). All subjects had signed informed consent, provided by their parents, for inclusion before participating in the study.</p>
<p>Two mL of whole saliva was collected from each child who was able to provide sputum into the Oragene RNA collection kit RE-100 (DNA Genotek Inc., Ottawa, ON, Canada). Saliva sampling was supervised and collected by trained personnel according to the instructions provided in the collection kit. In the case of children unable to spit voluntarily, sampling was done by a 2-mL syringe from under the tongues and gingival crevices, mainly with the help of the participating parents and/or caregivers. Briefly, children were recommended to refrain from eating and drinking for 1 h prior to sampling and also wash their mouths with drinking water at least 15 min before providing a sample. Once collected, the tube containing the sample was covered by placing the cap securely and inverting the container vigorously by hand vortexing for approximately 10 s, in order to allow the saliva to mix well with the Oragene RNA solution. Samples were then stored at −20 °C and subsequently transferred to the central laboratory at the Zanjan University of Medical Science (ZUMS) for further processing.</p>
</sec>
<sec id="sec4dot2-ijms-17-01711">
<title>4.2. Total RNA Preparation and cDNA Synthesis</title>
<p>Total RNA was extracted from whole saliva samples using a combination of two protocols: Oragene RNA collection kit RE-100 (DNA Genotek Inc., Ottawa, ON, Canada) and RNX-Plus solution (SinaClone BioScience, Tehran, Iran) with some modifications to the manufacturers’ instructions. Briefly, the saliva collected in the Oragene RNA collection kit was incubated in a water bath at 50 °C for 1 h. A 500-µL aliquot was then transferred into a 1.5-mL microcentrifuge tube and incubated in a water bath at 90 °C for 15 min. Twenty µL of the Neutralizer solution was added to the sample and vortexed for a few seconds, incubated on ice for 10 min, and centrifuged at 15,000× <italic>g</italic> for 3 min. The clear supernatant was then transferred into a new microcentrifuge tube, 2 volumes of cold 95% ethanol was added to the sample and mixed vigorously by hand. The sample was incubated at −20 °C for 30 min followed by centrifugation at 15,000× <italic>g</italic> for 3 min. The supernatant was discarded and the pellet was dissolved in 750 µL of RNX-Plus solution (SinaClone BioScience, Tehran, Iran) by vortexing, followed by incubation at room temperature for 5 min. A 200-μL volume of Chloroform was added to the solution and centrifuged for 15 min at 12,000× <italic>g</italic>. The upper phase was then transferred to a new microcentrifuge tube and an equal volume of isopropanol was added into the tube. The mixture was centrifuged for 15 min at 12,000× <italic>g</italic> and the resulting pellet was washed in 70% ethanol, air dried for 10 min, and dissolved in DEPC-treated ddH<sub>2</sub>O. The quality and quantity of extracted RNA samples were analyzed by fiber optic spectrophotometry using a NanoDrop 2000c (Thermo Scientific, Waltham, MA, USA). While RNA quantity was measured using the A<sub>260</sub> absorbance in DEPC-treated ddH<sub>2</sub>O, the RNA purity was monitored by A<sub>260</sub>/A<sub>280</sub> absorbance ratios of sample dilutions in Tris pH 7.4. RNA samples with A<sub>260</sub>/A<sub>280</sub> ratios of 1.8–2.1 were used for cDNA in the study. The average concentration of the RNA samples used in the study was 220 ± 132 ng/µL. Potential residual genomic DNA was eliminated with RNase-free DNase I digestion (Thermo Scientific). Complementary DNA (cDNA) was synthesized from 500-ng total DNase I treated RNA per reaction using the PrimScriptTM Reagent Kit (Takara Inc., Shiga, Japan) following the manufacturer’s instructions. Briefly, in a 10-µL reaction with 1× reaction buffer including MgCl<sub>2</sub> inside an RNase-free tube, the appropriate volume of RNA sample was first treated with 0.5 µL of DNase I (1 U/µL) by gently mixing the reaction and incubating it at 37 °C for 30 min, followed by inactivation of DNase I with addition of 1 µL of 50 mM EDTA and incubation at 65 °C for 10 min. This DNase I treated RNA sample (11 µL) was then used for cDNA synthesis in a 20-µL reaction containing 4 µL of 5× PrimeScript<sup>TM</sup> buffer, 1 µL of PrimeScript<sup>TM</sup> RT Enzyme mix I, 1 µL of 50 µM Oligo dT primer, 1 µL of 100 µM Random 6 mers, and 2 µL of RNase-free ddH<sub>2</sub>O. The RT reaction was mixed well and incubated at 37 °C for 15 min, followed by inactivation of the RT enzyme at 85 °C for 5 s. The cDNA samples were kept at −20 °C for further use.</p>
</sec>
<sec id="sec4dot3-ijms-17-01711">
<title>4.3. Candidate Reference Gene Selection</title>
<p>A total of 8 commonly used housekeeping genes with a wide range of biological functions were used in this study (see <xref ref-type="table" rid="ijms-17-01711-t002">Table 2</xref> for details). Six of the eight genes were picked from the internal control panel of genes offered by PrimerDesign Ltd. (Southampton, UK) with the following “anchor nucleotide” and “context sequence length” [<xref ref-type="bibr" rid="B39-ijms-17-01711">39</xref>] information for the primer sets: <italic>18s</italic>
<italic>rRNA</italic> (235, 99 bp), <italic>GAPDH</italic> (1087, 142 bp), <italic>RPL13A</italic> (727, 223 bp), <italic>SDHA</italic> (1032, 154 bp), <italic>UBC</italic> (452, 192 bp), and <italic>YWHAZ</italic> (2585, 150 bp). The remaining two genes included <italic>ACTB</italic>, and <italic>TFRC</italic> with the following forward and reverse primer sequences: ACTB_F, 5′-CGAGCACAGAGCCTCGCCTTTGCC-3′, ACTB_R, 5′-TGTCGACGACGAGCGCGGCGATAT-3′; and TFRC_F, 5′-ACCGGCACCATCAAGCT-3′, TFRC_R, 5′-TGATCACGCCAGACTTTGC-3′.</p>
</sec>
<sec id="sec4dot4-ijms-17-01711">
<title>4.4. Quantitative Real-Time PCR</title>
<p>The mRNA levels of the potential reference genes were quantified using Micro Amp Optical 8-Cap Strips (Life Technology, Pittsburgh, PA, USA) with an ABI 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Each 20-µL reaction contained 10 µL of RealQ Plus 2× PCR Master Mix Green, High ROX TM (Ampliqon Inc., Odense, Denmark), 25 ng of cDNA, and 300 nM of forward and reverse primers. PCR amplifications were performed in triplicates with an initial enzyme activation step at 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s (template denaturation), and 60 °C for 1 min (annealing and data collection). No-template controls (NTC) were included in each run. The inter-run technical variation was calculated as SD for three HKGs <italic>Cq</italic> values for a fixed repeated cDNA sample dilutions: <italic>ACTB</italic>, ±0.13; <italic>GAPDH</italic>, ±0.15; <italic>YWHAZ</italic>, ±0.14.</p>
</sec>
<sec id="sec4dot5-ijms-17-01711">
<title>4.5. Gene Expression Stability Analysis</title>
<p>Analysis of expression stability for the candidate reference genes was initially carried out by using two commonly used statistical algorithms, geNorm (qbasePLUS software v2.2, Biogazelle) [<xref ref-type="bibr" rid="B40-ijms-17-01711">40</xref>] and NormFinder (an Excel Add-in, provided by Molecular Diagnostic Labrotory, Dept. of Molecular Medicine, Aarhus University Hospital, Skejby Sygehus, Denmark) [<xref ref-type="bibr" rid="B41-ijms-17-01711">41</xref>], both of which are Visual Basic Applications for Microsoft Excel, in parallel. The raw <italic>Cq</italic> values in an Excel spread sheet were also fed into the BestKeeper applet (verison 1, <uri xlink:href="http://www.gene-quantification.com/bestkeeper.html" xlink:type="simple">http://www.gene-quantification.com/bestkeeper.html</uri>) [<xref ref-type="bibr" rid="B44-ijms-17-01711">44</xref>] for additional analysis.</p>
</sec>
</sec>
<sec id="sec5-ijms-17-01711">
<title>5. Conclusions</title>
<p>To our knowledge, the present study is the first systematic evaluation of candidate HKGs as internal controls for normalization of gene expression profiles in autistic children. Based on the analysis of eight commonly used HKGs by geNorm and NormFinder algorithms in parallel, a combination of the top two most stable candidate reference genes, <italic>GAPDH</italic> and <italic>YWHAZ</italic>, could be recommended for normalization of RT-qPCR analysis of salivary transcriptome in drug naïve non-syndromic autistic male children. We hope that the information presented here paves the way for: (1) systematic evaluation of reference genes in ASD studies under different experimental settings; and (2) using saliva as an alternative source of RNA, instead of the brain and blood, for transcriptome analysis in ASD research. As a readily-available and resourceful biofluid, saliva could open a noninvasive window to the complex molecular world of autism not only for diagnosis but also for surveillance of disease status and treatment.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported in part by Zanjan University of Medical Sciences (ZUMS) grant number A-12-534-1/-6-8. We would like to thank Khadijeh Babaei from the High Institute for Research and Education in Transfusion Medicine, Blood Transfusion Center, Tehran, for the preliminary set up of total RNA extractions from saliva. We are also thankful to Hamid Pezeshk (Department of Mathematics, Statistics, and Computer Science, University of Tehran) and Mohammad H. Rahbar (Department of Internal Medicine, UT Health Science Center at Houston) for their helpful comments and suggestions.</p>
</ack>
<app-group>
<app id="app1-ijms-17-01711">
<title>Supplementary Materials</title>
<p>Supplementary materials can be found at <uri xlink:href="www.mdpi.com/1422-0067/17/10/1711/s1" xlink:type="simple">www.mdpi.com/1422-0067/17/10/1711/s1</uri>.</p>
<supplementary-material content-type="local-data" id="ijms-17-01711-s001">
<media xlink:href="ijms-17-01711-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>Mehrdad Pedram and Yasin Panahi designed the study, and Mehrdad Pedram supervised the project. Yasin Panahi carried out the RT-qPCR experiments and did the geNorm and NormFinder analysis. Reza Shervin Badv and Mohammad Reza Eskandari were involved in the discussion and design of the scope of ASD patients for the study, and they also took care of the clinical examination of the patients, diagnosis, and clinical follow-ups. Fahimeh Salasar Moghaddam, Zahra Ghasemi, and Mandana Hadi Jafari did the saliva sample collection and processing. Yasin Panahi and Mehrdad Pedram analyzed the data. Yasin Panahi, Fahimeh Salasar Moghaddam, and Mandana Hadi Jafari wrote the initial draft of the manuscript, and Zahra Ghasemi provided the first draft of <xref ref-type="table" rid="ijms-17-01711-t001">Table 1</xref>. Mehrdad Pedram wrote and revised the full manuscript for submission. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<p>ACTB, β-actin protein; <italic>ACTB</italic>, β-actin gene; ASD, Autism spectrum disorders; Cq, Quantification Cycle; <italic>GAPDH</italic>, Glyceraldehyde-3-phosphate dehydrogenase gene; HKG, House Keeping Gene; MIQE, Minimum Information for Publication of Quantitative Real-Time PCR Experiments; RT-qPCR, Reverse Transcriptase Quantitative real-time PCR; <italic>UBC</italic>, Ubiquitin C gene; <italic>YWHAZ</italic>, Tyrosine 3 monooxygenase activation, zeta polypeptide gene.</p>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-ijms-17-01711">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lai</surname><given-names>M.C.</given-names></name><name><surname>Lombardo</surname><given-names>M.V.</given-names></name><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name></person-group>
<article-title>Autism</article-title>
<source/>Lancet
<year>2014</year>
<volume>383</volume>
<fpage>896</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id>
<pub-id pub-id-type="pmid">24074734</pub-id></element-citation>
</ref>
<ref id="B2-ijms-17-01711">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Risi</surname><given-names>S.</given-names></name><name><surname>DiLavore</surname><given-names>P.S.</given-names></name><name><surname>Shulman</surname><given-names>C.</given-names></name><name><surname>Thurm</surname><given-names>A.</given-names></name><name><surname>Pickles</surname><given-names>A.</given-names></name></person-group>
<article-title>Autism from 2 to 9 years of age</article-title>
<source/>Arch. Gen. Psychiatry
<year>2006</year>
<volume>63</volume>
<fpage>694</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.63.6.694</pub-id>
<pub-id pub-id-type="pmid">16754843</pub-id></element-citation>
</ref>
<ref id="B3-ijms-17-01711">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Werling</surname><given-names>D.M.</given-names></name><name><surname>Geschwind</surname><given-names>D.H.</given-names></name></person-group>
<article-title>Sex differences in autism spectrum disorders</article-title>
<source/>Curr. Opin. Neurol.
<year>2013</year>
<volume>26</volume>
<fpage>146</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0b013e32835ee548</pub-id>
<pub-id pub-id-type="pmid">23406909</pub-id></element-citation>
</ref>
<ref id="B4-ijms-17-01711">
<label>4.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Coleman</surname><given-names>M.</given-names></name></person-group>
<article-title>Etiological Heterogeneity in Autism Spectrum Disorders: Role of Rare Variants</article-title>
<source/>The Neuroscience of Autism Spectrum Disorders
<person-group person-group-type="editor"><name><surname>Joseph</surname><given-names>D.</given-names></name><name><surname>Buxbaum</surname><given-names>P.R.H.</given-names></name></person-group>
<publisher-name>Academic Press</publisher-name>
<publisher-loc>Waltham, MA, USA</publisher-loc>
<year>2013</year>
<fpage>113</fpage>
<lpage>144</lpage>
</element-citation>
</ref>
<ref id="B5-ijms-17-01711">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ch’ng</surname><given-names>C.</given-names></name><name><surname>Kwok</surname><given-names>W.</given-names></name><name><surname>Rogic</surname><given-names>S.</given-names></name><name><surname>Pavlidis</surname><given-names>P.</given-names></name></person-group>
<article-title>Meta-analysis of gene expression in autism spectrum disorder</article-title>
<source/>Autism Res.
<year>2015</year>
<volume>8</volume>
<fpage>593</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1475</pub-id>
<pub-id pub-id-type="pmid">25720351</pub-id></element-citation>
</ref>
<ref id="B6-ijms-17-01711">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berg</surname><given-names>J.M.</given-names></name><name><surname>Geschwind</surname><given-names>D.H.</given-names></name></person-group>
<article-title>Autism genetics: Searching for specificity and convergence</article-title>
<source/>Genome Biol.
<year>2012</year>
<volume>13</volume>
<fpage>247</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1186/gb-2012-13-7-247</pub-id>
<pub-id pub-id-type="pmid">22849751</pub-id></element-citation>
</ref>
<ref id="B7-ijms-17-01711">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morey</surname><given-names>J.S.</given-names></name><name><surname>Ryan</surname><given-names>J.C.</given-names></name><name><surname>van Dolah</surname><given-names>F.M.</given-names></name></person-group>
<article-title>Microarray validation: Factors influencing correlation between oligonucleotide microarrays and real-time PCR</article-title>
<source/>Biol. Proced. Online
<year>2006</year>
<volume>8</volume>
<fpage>175</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1251/bpo126</pub-id>
<pub-id pub-id-type="pmid">17242735</pub-id></element-citation>
</ref>
<ref id="B8-ijms-17-01711">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolan</surname><given-names>T.</given-names></name><name><surname>Hands</surname><given-names>R.E.</given-names></name><name><surname>Bustin</surname><given-names>S.A.</given-names></name></person-group>
<article-title>Quantification of mrna using real-time RT-PCR</article-title>
<source/>Nat. Protoc.
<year>2006</year>
<volume>1</volume>
<fpage>1559</fpage>
<lpage>1582</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2006.236</pub-id>
<pub-id pub-id-type="pmid">17406449</pub-id></element-citation>
</ref>
<ref id="B9-ijms-17-01711">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huggett</surname><given-names>J.</given-names></name><name><surname>Dheda</surname><given-names>K.</given-names></name><name><surname>Bustin</surname><given-names>S.</given-names></name><name><surname>Zumla</surname><given-names>A.</given-names></name></person-group>
<article-title>Real-time RT-PCR normalisation; strategies and considerations</article-title>
<source/>Genes Immun.
<year>2005</year>
<volume>6</volume>
<fpage>279</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="doi">10.1038/sj.gene.6364190</pub-id>
<pub-id pub-id-type="pmid">15815687</pub-id></element-citation>
</ref>
<ref id="B10-ijms-17-01711">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bustin</surname><given-names>S.A.</given-names></name><name><surname>Benes</surname><given-names>V.</given-names></name><name><surname>Garson</surname><given-names>J.A.</given-names></name><name><surname>Hellemans</surname><given-names>J.</given-names></name><name><surname>Huggett</surname><given-names>J.</given-names></name><name><surname>Kubista</surname><given-names>M.</given-names></name><name><surname>Mueller</surname><given-names>R.</given-names></name><name><surname>Nolan</surname><given-names>T.</given-names></name><name><surname>Pfaffl</surname><given-names>M.W.</given-names></name><name><surname>Shipley</surname><given-names>G.L.</given-names></name><etal></etal></person-group>
<article-title>The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments</article-title>
<source/>Clin. Chem.
<year>2009</year>
<volume>55</volume>
<fpage>611</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2008.112797</pub-id>
<pub-id pub-id-type="pmid">19246619</pub-id></element-citation>
</ref>
<ref id="B11-ijms-17-01711">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name></person-group>
<article-title>An old method facing a new challenge: Re-visiting housekeeping proteins as internal reference control for neuroscience research</article-title>
<source/>Life Sci.
<year>2013</year>
<volume>92</volume>
<fpage>747</fpage>
<lpage>751</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2013.02.014</pub-id>
<pub-id pub-id-type="pmid">23454168</pub-id></element-citation>
</ref>
<ref id="B12-ijms-17-01711">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Purcell</surname><given-names>A.E.</given-names></name><name><surname>Jeon</surname><given-names>O.H.</given-names></name><name><surname>Zimmerman</surname><given-names>A.W.</given-names></name><name><surname>Blue</surname><given-names>M.E.</given-names></name><name><surname>Pevsner</surname><given-names>J.</given-names></name></person-group>
<article-title>Postmortem brain abnormalities of the glutamate neurotransmitter system in autism</article-title>
<source/>Neurology
<year>2001</year>
<volume>57</volume>
<fpage>1618</fpage>
<lpage>1628</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.57.9.1618</pub-id>
<pub-id pub-id-type="pmid">11706102</pub-id></element-citation>
</ref>
<ref id="B13-ijms-17-01711">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S.H.</given-names></name><name><surname>Stary</surname><given-names>J.M.</given-names></name><name><surname>Halt</surname><given-names>A.R.</given-names></name><name><surname>Realmuto</surname><given-names>G.R.</given-names></name></person-group>
<article-title>Dysregulation of reelin and Bcl-2 proteins in autistic cerebellum</article-title>
<source/>J. Autism Dev. Disord.
<year>2001</year>
<volume>31</volume>
<fpage>529</fpage>
<lpage>535</lpage>
<pub-id pub-id-type="doi">10.1023/A:1013234708757</pub-id>
<pub-id pub-id-type="pmid">11814262</pub-id></element-citation>
</ref>
<ref id="B14-ijms-17-01711">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Araghi-Niknam</surname><given-names>M.</given-names></name><name><surname>Fatemi</surname><given-names>S.H.</given-names></name></person-group>
<article-title>Levels of Bcl-2 and p53 are altered in superior frontal and cerebellar cortices of autistic subjects</article-title>
<source/>Cell. Mol. Neurobiol.
<year>2003</year>
<volume>23</volume>
<fpage>945</fpage>
<lpage>952</lpage>
<pub-id pub-id-type="doi">10.1023/B:CEMN.0000005322.27203.73</pub-id>
<pub-id pub-id-type="pmid">14964781</pub-id></element-citation>
</ref>
<ref id="B15-ijms-17-01711">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Samaco</surname><given-names>R.C.</given-names></name><name><surname>Nagarajan</surname><given-names>R.P.</given-names></name><name><surname>Braunschweig</surname><given-names>D.</given-names></name><name><surname>LaSalle</surname><given-names>J.M.</given-names></name></person-group>
<article-title>Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders</article-title>
<source/>Hum. Mol. Genet.
<year>2004</year>
<volume>13</volume>
<fpage>629</fpage>
<lpage>639</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddh063</pub-id>
<pub-id pub-id-type="pmid">14734626</pub-id></element-citation>
</ref>
<ref id="B16-ijms-17-01711">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>V.W.</given-names></name><name><surname>Frank</surname><given-names>B.C.</given-names></name><name><surname>Heine</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>N.H.</given-names></name><name><surname>Quackenbush</surname><given-names>J.</given-names></name></person-group>
<article-title>Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes</article-title>
<source/>BMC Genom.
<year>2006</year>
<volume>7</volume>
<fpage>118</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-7-118</pub-id>
<pub-id pub-id-type="pmid">16709250</pub-id></element-citation>
</ref>
<ref id="B17-ijms-17-01711">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>Y.</given-names></name><name><surname>Martin</surname><given-names>C.L.</given-names></name><name><surname>Vazquez-Lopez</surname><given-names>A.</given-names></name><name><surname>Spence</surname><given-names>S.J.</given-names></name><name><surname>Alvarez-Retuerto</surname><given-names>A.I.</given-names></name><name><surname>Sigman</surname><given-names>M.</given-names></name><name><surname>Steindler</surname><given-names>C.</given-names></name><name><surname>Pellegrini</surname><given-names>S.</given-names></name><name><surname>Schanen</surname><given-names>N.C.</given-names></name><name><surname>Warren</surname><given-names>S.T.</given-names></name></person-group>
<article-title>Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways</article-title>
<source/>Hum. Mol. Genet.
<year>2007</year>
<volume>16</volume>
<fpage>1682</fpage>
<lpage>1698</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddm116</pub-id>
<pub-id pub-id-type="pmid">17519220</pub-id></element-citation>
</ref>
<ref id="B18-ijms-17-01711">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garbett</surname><given-names>K.</given-names></name><name><surname>Ebert</surname><given-names>P.J.</given-names></name><name><surname>Mitchell</surname><given-names>A.</given-names></name><name><surname>Lintas</surname><given-names>C.</given-names></name><name><surname>Manzi</surname><given-names>B.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><name><surname>Persico</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Immune transcriptome alterations in the temporal cortex of subjects with autism</article-title>
<source/>Neurobiol. Dis.
<year>2008</year>
<volume>30</volume>
<fpage>303</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2008.01.012</pub-id>
<pub-id pub-id-type="pmid">18378158</pub-id></element-citation>
</ref>
<ref id="B19-ijms-17-01711">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gregg</surname><given-names>J.P.</given-names></name><name><surname>Lit</surname><given-names>L.</given-names></name><name><surname>Baron</surname><given-names>C.A.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><name><surname>Walker</surname><given-names>W.</given-names></name><name><surname>Davis</surname><given-names>R.A.</given-names></name><name><surname>Croen</surname><given-names>L.A.</given-names></name><name><surname>Ozonoff</surname><given-names>S.</given-names></name><name><surname>Hansen</surname><given-names>R.</given-names></name><name><surname>Pessah</surname><given-names>I.N.</given-names></name></person-group>
<article-title>Gene expression changes in children with autism</article-title>
<source/>Genomics
<year>2008</year>
<volume>91</volume>
<fpage>22</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.ygeno.2007.09.003</pub-id>
<pub-id pub-id-type="pmid">18006270</pub-id></element-citation>
</ref>
<ref id="B20-ijms-17-01711">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Enstrom</surname><given-names>A.M.</given-names></name><name><surname>Lit</surname><given-names>L.</given-names></name><name><surname>Onore</surname><given-names>C.E.</given-names></name><name><surname>Gregg</surname><given-names>J.P.</given-names></name><name><surname>Hansen</surname><given-names>R.L.</given-names></name><name><surname>Pessah</surname><given-names>I.N.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><name><surname>van de Water</surname><given-names>J.A.</given-names></name><name><surname>Sharp</surname><given-names>F.R.</given-names></name><name><surname>Ashwood</surname><given-names>P.</given-names></name></person-group>
<article-title>Altered gene expression and function of peripheral blood natural killer cells in children with autism</article-title>
<source/>Brain Behav. Immun.
<year>2009</year>
<volume>23</volume>
<fpage>124</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2008.08.001</pub-id>
<pub-id pub-id-type="pmid">18762240</pub-id></element-citation>
</ref>
<ref id="B21-ijms-17-01711">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>V.W.</given-names></name><name><surname>Sarachana</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Nguyen</surname><given-names>A.</given-names></name><name><surname>Kulkarni</surname><given-names>S.</given-names></name><name><surname>Steinberg</surname><given-names>M.E.</given-names></name><name><surname>Luu</surname><given-names>T.</given-names></name><name><surname>Lai</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>N.H.</given-names></name></person-group>
<article-title>Gene expression profiling differentiates autism case–controls and phenotypic variants of autism spectrum disorders: Evidence for circadian rhythm dysfunction in severe autism</article-title>
<source/>Autism Res.
<year>2009</year>
<volume>2</volume>
<fpage>78</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1002/aur.73</pub-id>
<pub-id pub-id-type="pmid">19418574</pub-id></element-citation>
</ref>
<ref id="B22-ijms-17-01711">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>V.W.</given-names></name><name><surname>Nguyen</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Steinberg</surname><given-names>M.E.</given-names></name><name><surname>Sarachana</surname><given-names>T.</given-names></name><name><surname>Scully</surname><given-names>M.A.</given-names></name><name><surname>Soldin</surname><given-names>S.J.</given-names></name><name><surname>Luu</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>N.H.</given-names></name></person-group>
<article-title>Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: Altered pathways in neuronal development and steroid biosynthesis</article-title>
<source/>PLoS ONE
<year>2009</year>
<volume>4</volume>
<elocation-id>1711</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0005775</pub-id>
<pub-id pub-id-type="pmid">19492049</pub-id></element-citation>
</ref>
<ref id="B23-ijms-17-01711">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wen</surname><given-names>G.</given-names></name><name><surname>Tauqeer</surname><given-names>Z.</given-names></name><name><surname>Brown</surname><given-names>W.</given-names></name><name><surname>Malik</surname><given-names>M.</given-names></name></person-group>
<article-title>Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects</article-title>
<source/>Neuroscience
<year>2010</year>
<volume>165</volume>
<fpage>363</fpage>
<lpage>370</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.10.035</pub-id>
<pub-id pub-id-type="pmid">19854241</pub-id></element-citation>
</ref>
<ref id="B24-ijms-17-01711">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malik</surname><given-names>M.</given-names></name><name><surname>Sheikh</surname><given-names>A.M.</given-names></name><name><surname>Wen</surname><given-names>G.</given-names></name><name><surname>Spivack</surname><given-names>W.</given-names></name><name><surname>Brown</surname><given-names>W.T.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group>
<article-title>Expression of inflammatory cytokines, Bcl-2 and cathepsin D are altered in lymphoblasts of autistic subjects</article-title>
<source/>Immunobiology
<year>2011</year>
<volume>216</volume>
<fpage>80</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1016/j.imbio.2010.03.001</pub-id>
<pub-id pub-id-type="pmid">20399529</pub-id></element-citation>
</ref>
<ref id="B25-ijms-17-01711">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuwano</surname><given-names>Y.</given-names></name><name><surname>Kamio</surname><given-names>Y.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Katsuura</surname><given-names>S.</given-names></name><name><surname>Inada</surname><given-names>N.</given-names></name><name><surname>Takaki</surname><given-names>A.</given-names></name><name><surname>Rokutan</surname><given-names>K.</given-names></name></person-group>
<article-title>Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children</article-title>
<source/>PLoS ONE
<year>2011</year>
<volume>6</volume>
<elocation-id>1711</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0024723</pub-id>
<pub-id pub-id-type="pmid">21935445</pub-id></element-citation>
</ref>
<ref id="B26-ijms-17-01711">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghahramani Seno</surname><given-names>M.M.</given-names></name><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Gwadry</surname><given-names>F.G.</given-names></name><name><surname>Pinto</surname><given-names>D.</given-names></name><name><surname>Marshall</surname><given-names>C.R.</given-names></name><name><surname>Casallo</surname><given-names>G.</given-names></name><name><surname>Scherer</surname><given-names>S.W.</given-names></name></person-group>
<article-title>Gene and miRNA expression profiles in autism spectrum disorders</article-title>
<source/>Brain Res.
<year>2011</year>
<volume>1380</volume>
<fpage>85</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.046</pub-id>
<pub-id pub-id-type="pmid">20868653</pub-id></element-citation>
</ref>
<ref id="B27-ijms-17-01711">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Sanders</surname><given-names>S.J.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Voineagu</surname><given-names>I.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Chu</surname><given-names>S.H.</given-names></name><name><surname>Klei</surname><given-names>L.</given-names></name><name><surname>Cai</surname><given-names>C.</given-names></name><name><surname>Ou</surname><given-names>J.</given-names></name><name><surname>Lowe</surname><given-names>J.K.</given-names></name></person-group>
<article-title>Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders</article-title>
<source/>Am. J. Hum. Genet.
<year>2012</year>
<volume>91</volume>
<fpage>38</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.05.011</pub-id>
<pub-id pub-id-type="pmid">22726847</pub-id></element-citation>
</ref>
<ref id="B28-ijms-17-01711">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chow</surname><given-names>M.L.</given-names></name><name><surname>Pramparo</surname><given-names>T.</given-names></name><name><surname>Winn</surname><given-names>M.E.</given-names></name><name><surname>Barnes</surname><given-names>C.C.</given-names></name><name><surname>Li</surname><given-names>H.-R.</given-names></name><name><surname>Weiss</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>J.-B.</given-names></name><name><surname>Murray</surname><given-names>S.</given-names></name><name><surname>April</surname><given-names>C.</given-names></name><name><surname>Belinson</surname><given-names>H.</given-names></name></person-group>
<article-title>Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages</article-title>
<source/>PLoS Genet.
<year>2012</year>
<volume>8</volume>
<elocation-id>1711</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002592</pub-id>
<pub-id pub-id-type="pmid">22457638</pub-id></element-citation>
</ref>
<ref id="B29-ijms-17-01711">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kong</surname><given-names>S.W.</given-names></name><name><surname>Collins</surname><given-names>C.D.</given-names></name><name><surname>Shimizu-Motohashi</surname><given-names>Y.</given-names></name><name><surname>Holm</surname><given-names>I.A.</given-names></name><name><surname>Campbell</surname><given-names>M.G.</given-names></name><name><surname>Lee</surname><given-names>I.-H.</given-names></name><name><surname>Brewster</surname><given-names>S.J.</given-names></name><name><surname>Hanson</surname><given-names>E.</given-names></name><name><surname>Harris</surname><given-names>H.K.</given-names></name><name><surname>Lowe</surname><given-names>K.R.</given-names></name></person-group>
<article-title>Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders</article-title>
<source/>PLoS ONE
<year>2012</year>
<volume>7</volume>
<elocation-id>1711</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0049475</pub-id>
<pub-id pub-id-type="pmid">23227143</pub-id></element-citation>
</ref>
<ref id="B30-ijms-17-01711">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Griesi-Oliveira</surname><given-names>K.</given-names></name><name><surname>Moreira Dde</surname><given-names>P.</given-names></name><name><surname>Davis-Wright</surname><given-names>N.</given-names></name><name><surname>Sanders</surname><given-names>S.</given-names></name><name><surname>Mason</surname><given-names>C.</given-names></name><name><surname>Orabona</surname><given-names>G.M.</given-names></name><name><surname>Vadasz</surname><given-names>E.</given-names></name><name><surname>Bertola</surname><given-names>D.R.</given-names></name><name><surname>State</surname><given-names>M.W.</given-names></name><name><surname>Passos-Bueno</surname><given-names>M.R.</given-names></name></person-group>
<article-title>A complex chromosomal rearrangement involving chromosomes 2, 5, and X in autism spectrum disorder</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<year>2012</year>
<volume>159</volume>
<fpage>529</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32059</pub-id>
<pub-id pub-id-type="pmid">22592906</pub-id></element-citation>
</ref>
<ref id="B31-ijms-17-01711">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anitha</surname><given-names>A.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Thanseem</surname><given-names>I.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Iwayama</surname><given-names>Y.</given-names></name><name><surname>Toyota</surname><given-names>T.</given-names></name><name><surname>Matsuzaki</surname><given-names>H.</given-names></name><name><surname>Miyachi</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>S.</given-names></name><name><surname>Tsujii</surname><given-names>M.</given-names></name><etal></etal></person-group>
<article-title>Brain region-specific altered expression and association of mitochondria-related genes in autism</article-title>
<source/>Mol. Autism
<year>2012</year>
<volume>3</volume>
<fpage>12</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-12</pub-id>
<pub-id pub-id-type="pmid">23116158</pub-id></element-citation>
</ref>
<ref id="B32-ijms-17-01711">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ginsberg</surname><given-names>M.R.</given-names></name><name><surname>Rubin</surname><given-names>R.A.</given-names></name><name><surname>Falcone</surname><given-names>T.</given-names></name><name><surname>Ting</surname><given-names>A.H.</given-names></name><name><surname>Natowicz</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Brain transcriptional and epigenetic associations with autism</article-title>
<source/>PLoS ONE
<year>2012</year>
<volume>7</volume>
<elocation-id>1711</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0044736</pub-id>
<pub-id pub-id-type="pmid">22984548</pub-id></element-citation>
</ref>
<ref id="B33-ijms-17-01711">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Ababon</surname><given-names>M.R.</given-names></name><name><surname>Soliman</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Brzustowicz</surname><given-names>L.M.</given-names></name><name><surname>Matteson</surname><given-names>P.G.</given-names></name><name><surname>Millonig</surname><given-names>J.H.</given-names></name></person-group>
<article-title>Autism associated gene, engrailed2, and flanking gene levels are altered in post-mortem cerebellum</article-title>
<source/>PLoS ONE
<year>2014</year>
<volume>9</volume>
<elocation-id>1711</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0087208</pub-id>
<pub-id pub-id-type="pmid">24520327</pub-id></element-citation>
</ref>
<ref id="B34-ijms-17-01711">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nardone</surname><given-names>S.</given-names></name><name><surname>Sams</surname><given-names>D.S.</given-names></name><name><surname>Reuveni</surname><given-names>E.</given-names></name><name><surname>Getselter</surname><given-names>D.</given-names></name><name><surname>Oron</surname><given-names>O.</given-names></name><name><surname>Karpuj</surname><given-names>M.</given-names></name><name><surname>Elliott</surname><given-names>E.</given-names></name></person-group>
<article-title>DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways</article-title>
<source/>Transl. Psychiatry
<year>2014</year>
<volume>4</volume>
<fpage>e433</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2014.70</pub-id>
<pub-id pub-id-type="pmid">25180572</pub-id></element-citation>
</ref>
<ref id="B35-ijms-17-01711">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pandit</surname><given-names>P.</given-names></name><name><surname>Cooper-White</surname><given-names>J.</given-names></name><name><surname>Punyadeera</surname><given-names>C.</given-names></name></person-group>
<article-title>High-yield RNA-extraction method for saliva</article-title>
<source/>Clin. Chem.
<year>2013</year>
<volume>59</volume>
<fpage>1118</fpage>
<lpage>1122</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2012.197863</pub-id>
<pub-id pub-id-type="pmid">23564756</pub-id></element-citation>
</ref>
<ref id="B36-ijms-17-01711">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Reiss</surname><given-names>J.K.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Chia</surname><given-names>D.</given-names></name><name><surname>Wong</surname><given-names>D.T.</given-names></name></person-group>
<article-title>Direct saliva transcriptome analysis</article-title>
<source/>Clin. Chem.
<year>2011</year>
<volume>57</volume>
<fpage>1295</fpage>
<lpage>1302</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2010.159210</pub-id>
<pub-id pub-id-type="pmid">21791578</pub-id></element-citation>
</ref>
<ref id="B37-ijms-17-01711">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>N.J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Brinkman</surname><given-names>B.M.</given-names></name><name><surname>Wong</surname><given-names>D.T.</given-names></name></person-group>
<article-title>Characterization of RNA in saliva</article-title>
<source/>Clin. Chem.
<year>2006</year>
<volume>52</volume>
<fpage>988</fpage>
<lpage>994</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2005.063206</pub-id>
<pub-id pub-id-type="pmid">16601067</pub-id></element-citation>
</ref>
<ref id="B38-ijms-17-01711">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seugnet</surname><given-names>L.</given-names></name><name><surname>Boero</surname><given-names>J.</given-names></name><name><surname>Gottschalk</surname><given-names>L.</given-names></name><name><surname>Duntley</surname><given-names>S.P.</given-names></name><name><surname>Shaw</surname><given-names>P.J.</given-names></name></person-group>
<article-title>Identification of a biomarker for sleep drive in flies and humans</article-title>
<source/>Proc. Natl. Acad. Sci. USA
<year>2006</year>
<volume>103</volume>
<fpage>19913</fpage>
<lpage>19918</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0609463104</pub-id>
<pub-id pub-id-type="pmid">17167051</pub-id></element-citation>
</ref>
<ref id="B39-ijms-17-01711">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bustin</surname><given-names>S.A.</given-names></name><name><surname>Benes</surname><given-names>V.</given-names></name><name><surname>Garson</surname><given-names>J.A.</given-names></name><name><surname>Hellemans</surname><given-names>J.</given-names></name><name><surname>Huggett</surname><given-names>J.</given-names></name><name><surname>Kubista</surname><given-names>M.</given-names></name><name><surname>Mueller</surname><given-names>R.</given-names></name><name><surname>Nolan</surname><given-names>T.</given-names></name><name><surname>Pfaffl</surname><given-names>M.W.</given-names></name><name><surname>Shipley</surname><given-names>G.L.</given-names></name></person-group>
<article-title>Primer sequence disclosure: A clarification of the MIQE guidelines</article-title>
<source/>Clin. Chem.
<year>2011</year>
<volume>57</volume>
<fpage>919</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2011.162958</pub-id>
<pub-id pub-id-type="pmid">21421813</pub-id></element-citation>
</ref>
<ref id="B40-ijms-17-01711">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vandesompele</surname><given-names>J.</given-names></name><name><surname>de Preter</surname><given-names>K.</given-names></name><name><surname>Pattyn</surname><given-names>F.</given-names></name><name><surname>Poppe</surname><given-names>B.</given-names></name><name><surname>van Roy</surname><given-names>N.</given-names></name><name><surname>de Paepe</surname><given-names>A.</given-names></name><name><surname>Speleman</surname><given-names>F.</given-names></name></person-group>
<article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes</article-title>
<source/>Genome Biol.
<year>2002</year>
<volume>3</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1186/gb-2002-3-7-research0034</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-17-01711">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andersen</surname><given-names>C.L.</given-names></name><name><surname>Jensen</surname><given-names>J.L.</given-names></name><name><surname>Orntoft</surname><given-names>T.F.</given-names></name></person-group>
<article-title>Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets</article-title>
<source/>Cancer Res.
<year>2004</year>
<volume>64</volume>
<fpage>5245</fpage>
<lpage>5250</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-0496</pub-id>
<pub-id pub-id-type="pmid">15289330</pub-id></element-citation>
</ref>
<ref id="B42-ijms-17-01711">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lallemant</surname><given-names>B.</given-names></name><name><surname>Evrard</surname><given-names>A.</given-names></name><name><surname>Combescure</surname><given-names>C.</given-names></name><name><surname>Chapuis</surname><given-names>H.</given-names></name><name><surname>Chambon</surname><given-names>G.</given-names></name><name><surname>Raynal</surname><given-names>C.</given-names></name><name><surname>Reynaud</surname><given-names>C.</given-names></name><name><surname>Sabra</surname><given-names>O.</given-names></name><name><surname>Joubert</surname><given-names>D.</given-names></name><name><surname>Hollande</surname><given-names>F.</given-names></name><etal></etal></person-group>
<article-title>Reference gene selection for head and neck squamous cell carcinoma gene expression studies</article-title>
<source/>BMC Mol. Biol.
<year>2009</year>
<volume>10</volume>
<fpage>78</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1186/1471-2199-10-78</pub-id>
<pub-id pub-id-type="pmid">19650912</pub-id></element-citation>
</ref>
<ref id="B43-ijms-17-01711">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Livak</surname><given-names>K.J.</given-names></name><name><surname>Schmittgen</surname><given-names>T.D.</given-names></name></person-group>
<article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>−∆∆<italic>C</italic>t</sup> method</article-title>
<source/>Methods
<year>2001</year>
<volume>25</volume>
<fpage>402</fpage>
<lpage>408</lpage>
<pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
<pub-id pub-id-type="pmid">11846609</pub-id></element-citation>
</ref>
<ref id="B44-ijms-17-01711">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pfaffl</surname><given-names>M.W.</given-names></name><name><surname>Tichopad</surname><given-names>A.</given-names></name><name><surname>Prgomet</surname><given-names>C.</given-names></name><name><surname>Neuvians</surname><given-names>T.P.</given-names></name></person-group>
<article-title>Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: Bestkeeper—Excel-based tool using pair-wise correlations</article-title>
<source/>Biotechnol. Lett.
<year>2004</year>
<volume>26</volume>
<fpage>509</fpage>
<lpage>515</lpage>
<pub-id pub-id-type="doi">10.1023/B:BILE.0000019559.84305.47</pub-id>
<pub-id pub-id-type="pmid">15127793</pub-id></element-citation>
</ref>
<ref id="B45-ijms-17-01711">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keller</surname><given-names>S.</given-names></name><name><surname>Sarchiapone</surname><given-names>M.</given-names></name><name><surname>Zarrilli</surname><given-names>F.</given-names></name><name><surname>Videtic</surname><given-names>A.</given-names></name><name><surname>Ferraro</surname><given-names>A.</given-names></name><name><surname>Carli</surname><given-names>V.</given-names></name><name><surname>Sacchetti</surname><given-names>S.</given-names></name><name><surname>Lembo</surname><given-names>F.</given-names></name><name><surname>Angiolillo</surname><given-names>A.</given-names></name><name><surname>Jovanovic</surname><given-names>N.</given-names></name><etal></etal></person-group>
<article-title>Increased BDNF promoter methylation in the Wernicke area of suicide subjects</article-title>
<source/>Arch. Gen. Psychiatry
<year>2010</year>
<volume>67</volume>
<fpage>258</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2010.9</pub-id>
<pub-id pub-id-type="pmid">20194826</pub-id></element-citation>
</ref>
<ref id="B46-ijms-17-01711">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arion</surname><given-names>D.</given-names></name><name><surname>Sabatini</surname><given-names>M.</given-names></name><name><surname>Unger</surname><given-names>T.</given-names></name><name><surname>Pastor</surname><given-names>J.</given-names></name><name><surname>Alonso-Nanclares</surname><given-names>L.</given-names></name><name><surname>Ballesteros-Yanez</surname><given-names>I.</given-names></name><name><surname>Garcia Sola</surname><given-names>R.</given-names></name><name><surname>Munoz</surname><given-names>A.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><name><surname>DeFelipe</surname><given-names>J.</given-names></name></person-group>
<article-title>Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy</article-title>
<source/>Neurobiol. Dis.
<year>2006</year>
<volume>22</volume>
<fpage>374</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2005.12.012</pub-id>
<pub-id pub-id-type="pmid">16480884</pub-id></element-citation>
</ref>
<ref id="B47-ijms-17-01711">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arion</surname><given-names>D.</given-names></name><name><surname>Unger</surname><given-names>T.</given-names></name><name><surname>Lewis</surname><given-names>D.A.</given-names></name><name><surname>Levitt</surname><given-names>P.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name></person-group>
<article-title>Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia</article-title>
<source/>Biol. Psychiatry
<year>2007</year>
<volume>62</volume>
<fpage>711</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.12.021</pub-id>
<pub-id pub-id-type="pmid">17568569</pub-id></element-citation>
</ref>
<ref id="B48-ijms-17-01711">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Wong</surname><given-names>D.T.</given-names></name></person-group>
<article-title>Salivary biomarkers for clinical applications</article-title>
<source/>Mol. Diagn. Ther.
<year>2009</year>
<volume>13</volume>
<fpage>245</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1007/BF03256330</pub-id>
<pub-id pub-id-type="pmid">19712004</pub-id></element-citation>
</ref>
<ref id="B49-ijms-17-01711">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saxena</surname><given-names>V.</given-names></name><name><surname>Yadev</surname><given-names>N.</given-names></name><name><surname>Juneja</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Tiwari</surname><given-names>U.</given-names></name><name><surname>Santha</surname><given-names>B.</given-names></name></person-group>
<article-title>Saliva: A miraculous biofluid for early detection of disease</article-title>
<source/>J. Oral Health Community Dent.
<year>2013</year>
<volume>7</volume>
<fpage>64</fpage>
<lpage>68</lpage>
</element-citation>
</ref>
<ref id="B50-ijms-17-01711">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Karlan</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Gross</surname><given-names>J.</given-names></name><name><surname>Elashoff</surname><given-names>D.</given-names></name><name><surname>Akin</surname><given-names>D.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name><name><surname>Chia</surname><given-names>D.</given-names></name><name><surname>Karlan</surname><given-names>B.</given-names></name><etal></etal></person-group>
<article-title>Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer</article-title>
<source/>PLoS ONE
<year>2010</year>
<volume>5</volume>
<elocation-id>1711</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0015573</pub-id>
<pub-id pub-id-type="pmid">21217834</pub-id></element-citation>
</ref>
<ref id="B51-ijms-17-01711">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nohesara</surname><given-names>S.</given-names></name><name><surname>Ghadirivasfi</surname><given-names>M.</given-names></name><name><surname>Mostafavi</surname><given-names>S.</given-names></name><name><surname>Eskandari</surname><given-names>M.R.</given-names></name><name><surname>Ahmadkhaniha</surname><given-names>H.</given-names></name><name><surname>Thiagalingam</surname><given-names>S.</given-names></name><name><surname>Abdolmaleky</surname><given-names>H.M.</given-names></name></person-group>
<article-title>DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder</article-title>
<source/>J. Psychiatr. Res.
<year>2011</year>
<volume>45</volume>
<fpage>1432</fpage>
<lpage>1438</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2011.06.013</pub-id>
<pub-id pub-id-type="pmid">21820670</pub-id></element-citation>
</ref>
<ref id="B52-ijms-17-01711">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahbar</surname><given-names>M.H.</given-names></name><name><surname>Samms-Vaughan</surname><given-names>M.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Bressler</surname><given-names>J.</given-names></name><name><surname>Dickerson</surname><given-names>A.S.</given-names></name><name><surname>Hessabi</surname><given-names>M.</given-names></name><name><surname>Loveland</surname><given-names>K.A.</given-names></name><name><surname>Grove</surname><given-names>M.L.</given-names></name><name><surname>Shakespeare-Pellington</surname><given-names>S.</given-names></name><name><surname>Beecher</surname><given-names>C.</given-names></name><etal></etal></person-group>
<article-title>Synergic effect of GSTP1 and blood manganese concentrations in autism spectrum disorder</article-title>
<source/>Res. Autism Spectr. Disord.
<year>2015</year>
<volume>18</volume>
<fpage>73</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.rasd.2015.08.001</pub-id>
<pub-id pub-id-type="pmid">26309447</pub-id></element-citation>
</ref>
<ref id="B53-ijms-17-01711">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hicks</surname><given-names>S.D.</given-names></name><name><surname>Ignacio</surname><given-names>C.</given-names></name><name><surname>Gentile</surname><given-names>K.</given-names></name><name><surname>Middleton</surname><given-names>F.A.</given-names></name></person-group>
<article-title>Salivary mirna profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate asd candidate genes involved in neurodevelopment</article-title>
<source/>BMC Pediatr.
<year>2016</year>
<volume>16</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1186/s12887-016-0586-x</pub-id>
<pub-id pub-id-type="pmid">26728595</pub-id></element-citation>
</ref>
<ref id="B54-ijms-17-01711">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Farrell</surname><given-names>J.J.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Elashoff</surname><given-names>D.</given-names></name><name><surname>Akin</surname><given-names>D.</given-names></name><name><surname>Park</surname><given-names>N.H.</given-names></name><name><surname>Chia</surname><given-names>D.</given-names></name><name><surname>Wong</surname><given-names>D.T.</given-names></name></person-group>
<article-title>Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer</article-title>
<source/>Gastroenterology
<year>2010</year>
<volume>138</volume>
<fpage>941</fpage>
<lpage>947</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2009.11.010</pub-id>
<pub-id pub-id-type="pmid">19931263</pub-id></element-citation>
</ref>
<ref id="B55-ijms-17-01711">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>H.R.</given-names></name><name><surname>Kuo</surname><given-names>H.C.</given-names></name><name><surname>Huang</surname><given-names>H.C.</given-names></name><name><surname>Huang</surname><given-names>L.T.</given-names></name><name><surname>Tain</surname><given-names>Y.L.</given-names></name><name><surname>Chen</surname><given-names>C.C.</given-names></name><name><surname>Liang</surname><given-names>C.D.</given-names></name><name><surname>Sheen</surname><given-names>J.M.</given-names></name><name><surname>Lin</surname><given-names>I.C.</given-names></name><name><surname>Wu</surname><given-names>C.C.</given-names></name><etal></etal></person-group>
<article-title>Glyceraldehyde-3-phosphate dehydrogenase is a reliable internal control in western blot analysis of leukocyte subpopulations from children</article-title>
<source/>Anal. Biochem.
<year>2011</year>
<volume>413</volume>
<fpage>24</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.ab.2011.01.037</pub-id>
<pub-id pub-id-type="pmid">21284931</pub-id></element-citation>
</ref>
<ref id="B56-ijms-17-01711">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Sochivko</surname><given-names>D.</given-names></name><name><surname>Beck</surname><given-names>H.</given-names></name><name><surname>Marechal</surname><given-names>D.</given-names></name><name><surname>Wiestler</surname><given-names>O.D.</given-names></name><name><surname>Becker</surname><given-names>A.J.</given-names></name></person-group>
<article-title>Activity-induced expression of common reference genes in individual cns neurons</article-title>
<source/>Lab. Investig.
<year>2001</year>
<volume>81</volume>
<fpage>913</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="doi">10.1038/labinvest.3780300</pub-id>
<pub-id pub-id-type="pmid">11406652</pub-id></element-citation>
</ref>
<ref id="B57-ijms-17-01711">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silberberg</surname><given-names>G.</given-names></name><name><surname>Baruch</surname><given-names>K.</given-names></name><name><surname>Navon</surname><given-names>R.</given-names></name></person-group>
<article-title>Detection of stable reference genes for real-time PCR analysis in schizophrenia and bipolar disorder</article-title>
<source/>Anal. Biochem.
<year>2009</year>
<volume>391</volume>
<fpage>91</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1016/j.ab.2009.05.026</pub-id>
<pub-id pub-id-type="pmid">19464249</pub-id></element-citation>
</ref>
<ref id="B58-ijms-17-01711">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Penna</surname><given-names>I.</given-names></name><name><surname>Vella</surname><given-names>S.</given-names></name><name><surname>Gigoni</surname><given-names>A.</given-names></name><name><surname>Russo</surname><given-names>C.</given-names></name><name><surname>Cancedda</surname><given-names>R.</given-names></name><name><surname>Pagano</surname><given-names>A.</given-names></name></person-group>
<article-title>Selection of candidate housekeeping genes for normalization in human postmortem brain samples</article-title>
<source/>Int. J. Mol. Sci.
<year>2011</year>
<volume>12</volume>
<fpage>5461</fpage>
<lpage>5470</lpage>
<pub-id pub-id-type="doi">10.3390/ijms12095461</pub-id>
<pub-id pub-id-type="pmid">22016602</pub-id></element-citation>
</ref>
<ref id="B59-ijms-17-01711">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steinhausen</surname><given-names>H.C.</given-names></name><name><surname>Erdin</surname><given-names>A.</given-names></name></person-group>
<article-title>Abnormal psychosocial situations and ICD-10 diagnoses in children and adolescents attending a psychiatric service</article-title>
<source/>J. Child Psychol. Psychiatry
<year>1992</year>
<volume>33</volume>
<fpage>731</fpage>
<lpage>740</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.1992.tb00908.x</pub-id>
<pub-id pub-id-type="pmid">1601946</pub-id></element-citation>
</ref>
<ref id="B60-ijms-17-01711">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Pickles</surname><given-names>A.</given-names></name><name><surname>McLennan</surname><given-names>J.</given-names></name><name><surname>Rutter</surname><given-names>M.</given-names></name><name><surname>Bregman</surname><given-names>J.</given-names></name><name><surname>Folstein</surname><given-names>S.</given-names></name><name><surname>Fombonne</surname><given-names>E.</given-names></name><name><surname>Leboyer</surname><given-names>M.</given-names></name><name><surname>Minshew</surname><given-names>N.</given-names></name></person-group>
<article-title>Diagnosing autism: Analyses of data from the autism diagnostic interview</article-title>
<source/>J. Autism Dev. Disord.
<year>1997</year>
<volume>27</volume>
<fpage>501</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1023/A:1025873925661</pub-id>
<pub-id pub-id-type="pmid">9403369</pub-id></element-citation>
</ref>
<ref id="B61-ijms-17-01711">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goodman</surname><given-names>R.</given-names></name></person-group>
<article-title>The strengths and difficulties questionnaire: A research note</article-title>
<source/>J. Child. Psychol. Psychiatry
<year>1997</year>
<volume>38</volume>
<fpage>581</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.1997.tb01545.x</pub-id>
<pub-id pub-id-type="pmid">9255702</pub-id></element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-17-01711-f001" position="float">
<label>Figure 1</label>
<caption>
<p>Expression stability analysis of the candidate reference genes in phase I. The stability of expression for 8 housekeeping genes tested in saliva is ranked (left to right) based on the least stable to the most stable gene by: (<bold>A</bold>) geNorm; and (<bold>B</bold>) NormFinder algorithms.</p>
</caption>
<graphic xlink:href="ijms-17-01711-g001"></graphic>
</fig>
<fig id="ijms-17-01711-f002" position="float">
<label>Figure 2</label>
<caption>
<p>Scatter plot representations of the <italic>Cq</italic> values measured for the final four candidate genes. Filled squares and circles represent the control and autistic groups, respectively. The vertical bars indicate the median and interquartile range. The bottom and top of each bar represent the 25th and 75th percentiles, respectively, and the line bisecting each bar shows the median <italic>Cq</italic> value.</p>
</caption>
<graphic xlink:href="ijms-17-01711-g002"></graphic>
</fig>
<fig id="ijms-17-01711-f003" position="float">
<label>Figure 3</label>
<caption>
<p>Expression stability analysis for the final four candidate reference genes in phase II. Expression of each candidate gene was examined in a total of 18 saliva samples (nine with childhood Autism and nine healthy controls) ranked compared with the rest by (<bold>A</bold>) geNorm and (<bold>B</bold>) NormFinder algorithms based on their stability of expression values; when the clinical group’s identifier was included in the NormFinder analysis, <italic>GAPDH</italic> and <italic>YWHAZ</italic> were selected as the best genes combined, in agreement with the geNorm pair-wise ranking.</p>
</caption>
<graphic xlink:href="ijms-17-01711-g003a"></graphic>
<graphic xlink:href="ijms-17-01711-g003b"></graphic>
</fig>
<fig id="ijms-17-01711-f004" position="float">
<label>Figure 4</label>
<caption>
<p>Comparison of the relative expression levels of candidate reference genes between the two groups. Colored and white boxes represent the autistic and control groups, respectively. The relative expression level for each gene was calculated by using either: (<bold>A</bold>) the <italic>GAPDH</italic> (glyceraldehyde-3-phosphate dehydrogenase); or (<bold>B</bold>) ACTB (β-actin) gene as the reference. Statistical analysis comparing the expression levels are done with Mann-Whitney <italic>U</italic> test (two-tailed), and the data are presented as the mean and interquartile range, with vertical bars representing the total range (<bold>B</bold>). <italic>p</italic>-values: (<bold>A</bold>) <italic>ACTB</italic> (<italic>p</italic> = 0.26), <italic>UBC</italic> (<italic>p</italic> = 0.45), <italic>YWHAZ</italic> (<italic>p</italic> = 0.82); and (<bold>B</bold>) <italic>GAPDH</italic> (<italic>p</italic> = 0.26), <italic>UBC</italic> (<italic>p</italic> = 0.03), <italic>YWHAZ</italic> (<italic>p</italic> = 0.26).</p>
</caption>
<graphic xlink:href="ijms-17-01711-g004a"></graphic>
<graphic xlink:href="ijms-17-01711-g004b"></graphic>
</fig>
<table-wrap id="ijms-17-01711-t001" position="float">
<object-id pub-id-type="pii">ijms-17-01711-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Internal control genes used in ASD gene expression studies.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">RNA/Protein Source</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference Gene(s)</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Age (Year)</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">N</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Sex</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Purcell et al. (2001) [<xref ref-type="bibr" rid="B12-ijms-17-01711">12</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="1" valign="middle">ACTIN <sup>WB</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">5–54</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">10</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F <sup>1</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cerebellum</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>
<sup>RP</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Fatemi et al. (2001) [<xref ref-type="bibr" rid="B13-ijms-17-01711">13</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">ACTIN <sup>WB</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">23.5 ± 4.8</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">5</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cerebellum</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Araghi-Niknam et al. (2003) [<xref ref-type="bibr" rid="B14-ijms-17-01711">14</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">ACTIN <sup>WB</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">23.8 ± 4.9</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">5</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cerebellum, Frontal Cortex</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Samaco et al. (2004) [<xref ref-type="bibr" rid="B15-ijms-17-01711">15</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>TFRC</italic> and <italic>ACTIN</italic>
<sup>IF</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">2–32</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">13</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F <sup>8</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Frontal Cortex</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>, <italic>H1</italic>, and <italic>TFRC</italic>
<sup>FISH</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hu et al. (2006) [<xref ref-type="bibr" rid="B16-ijms-17-01711">16</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LCL</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>18s rRNA</italic>
<sup>qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">6–16</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">10</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Nishimura et al. (2007 [<xref ref-type="bibr" rid="B17-ijms-17-01711">17</xref>])</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LCL</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>HPRT1</italic>
<sup>qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AGRE</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">42</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Garbett et al. (2008) [<xref ref-type="bibr" rid="B18-ijms-17-01711">18</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle"><italic>ACTB</italic>
<sup>MA−qP</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">4–30</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">6</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F <sup>2</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sup. temporal gyrus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Gregg et al. (2008) [<xref ref-type="bibr" rid="B19-ijms-17-01711">19</xref>]</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Whole blood</td>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>DDR1</italic>, <italic>RPL37A</italic>, and</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">CHARGE</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">35</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F <sup>6</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>SMARC2</italic>
<sup>MA−qP</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Enstrom et al. (2009) [<xref ref-type="bibr" rid="B20-ijms-17-01711">20</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PBL, Natural killer cells</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>DDR1</italic>, <italic>RPL37A</italic>, and <italic>SMARC2</italic>
<sup>MA−qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2.3–5.6</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">52</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hu et al. (2009a) [<xref ref-type="bibr" rid="B21-ijms-17-01711">21</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LCL</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>MDH1</italic>, <italic>ARF1</italic>, <italic>ACSL5</italic>
<sup>MA−qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">12.3 ± 3.7</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">116</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hu et al. (2009b) [<xref ref-type="bibr" rid="B22-ijms-17-01711">22</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LCL</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>18s rRNA</italic>
<sup>MA−qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7.8 ± 3.4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">20</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Sheikh et al. (2010) [<xref ref-type="bibr" rid="B23-ijms-17-01711">23</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">ACTIN <sup>WB</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">8.9 ± 3.2</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">9</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F <sup>4</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Frontal Cortex</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Malik et al. (2011) [<xref ref-type="bibr" rid="B24-ijms-17-01711">24</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PBL</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ACTIN <sup>WB, NB</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8.4 ± 0.3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">6</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kuwano et al. (2011) [<xref ref-type="bibr" rid="B25-ijms-17-01711">25</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Whole blood</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic> and <italic>HDAC1</italic>
<sup>MA−qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">26.7 ± 5.5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">21</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M/F <sup>4</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ghahramani Seno et al. (2011) [<xref ref-type="bibr" rid="B26-ijms-17-01711">26</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LCL</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>TMEM</italic>32 <sup>qP</sup>
<italic>TUBB</italic>
<sup>WB</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2–18</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">20</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M/F <sup>7</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Luo et al. (2012) [<xref ref-type="bibr" rid="B27-ijms-17-01711">27</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">LCL</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>
<sup>MA−qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SSC</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">42</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Chow et al. (2012) [<xref ref-type="bibr" rid="B28-ijms-17-01711">28</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>ACTB</italic>, <italic>TBP</italic>, and</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">2–56</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">20</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prefrontal Cortex</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>RPL13A</italic>
<sup>MA−qP</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kong et al. (2012) [<xref ref-type="bibr" rid="B29-ijms-17-01711">29</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Whole blood</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>
<sup>MA−qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8.2 ± 3.0</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">170</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Griesi-Oliveira et al. (2012) [<xref ref-type="bibr" rid="B30-ijms-17-01711">30</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dental pulp stem cells</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>, <italic>HPRT1</italic>, <italic>SDHA</italic>, and <italic>HMBS</italic>
<sup>qP</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">10</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">F</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Anitha et al. (2012) [<xref ref-type="bibr" rid="B31-ijms-17-01711">31</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>GAPDH</italic>
<sup>WB</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">8–29</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">8</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F <sup>2</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Anterior cingulated gyrus, Motor Cortex, thalamus</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>B2M</italic>, <italic>HPRT1</italic>, <italic>RPL13A</italic>, <italic>GAPDH</italic>, and <italic>ACTB</italic>
<sup>qP</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Ginsberg et al. (2012) [<xref ref-type="bibr" rid="B32-ijms-17-01711">32</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain tissue</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>
<sup>qP</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">2–60</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">9</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Occipital and cerebellar hemispheric cortices</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Choi et al. (2014) [<xref ref-type="bibr" rid="B33-ijms-17-01711">33</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain Tissue</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>
<sup>qP</sup></td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">4.5–82</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">29</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">M/F <sup>8</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cerebellum</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Nardone et al. (2014) [<xref ref-type="bibr" rid="B34-ijms-17-01711">34</xref>]</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Brain Tissue</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle"><italic>GAPDH</italic>, <italic>HPRT1</italic>, <italic>POLR2α</italic>, and <italic>SDHA</italic>
<sup>qP</sup></td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">18–51</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">13</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">M/F <sup>2</sup></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Anterior cingulated gyrus</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prefrontal Cortex</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>N, number of ASD samples; NA, not available; F <sup>N</sup>, number of female ASD samples; Regular capitalized abbreviations under the Reference Gene(s) columns are indicative of proteins, whereas the italicized ones denote RNA or mRNA. Sample sources: AGRE, Autism Genetic Resource Exchange; CHARGE, Childhood Autism Risks from Genetics and Environment; SSC, Simon Simplex Collection. Cell lines: LCL, Lymphoblastoid Cell Line; PBL, Peripheral Blood Lymphocyte. Techniques: FISH, Fluorescence in situ Hybridization; IF, Immunofluorescence; MA-qP, Microarray-RT-qPCR; qP, Reverse transcriptase quantitative real-time PCR; NB, Northern Blot; RP, semi-quantitative RT-PCR; WB, Western Blot.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="ijms-17-01711-t002" position="float">
<object-id pub-id-type="pii">ijms-17-01711-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>List of the housekeeping genes evaluated as candidate reference genes during the first phase.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene Name</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Function</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene Symbol</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">mRNA Accession No.</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Amplicon <sup>2</sup> Length (bp)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">18S ribosomal RNA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ribosomal RNA Subunit</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>18s</italic>
<italic>rRNA</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">M10098 <sup>1</sup></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">99 *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">β-actin</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cytoskeletal structural protein</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACTB</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NM_001101</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">94</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Glyceraldehyde-3-phosphate dehydrogenase</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Glycolytic enzyme</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>GAPDH</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NM_002046</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">142 *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ribosomal protein L13a</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Structural component of large subunit of Ribosome</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>RPL13A</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NM_012423</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">223 *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Succinate dehydrogenase complex subunit A, flavoprotein</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Electron transporter in the Krebs cycle</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>SDHA</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NM_004168</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">154 *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Transferrin receptor</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cellular iron uptake</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>TFRC</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NM_003234</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">134</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ubiquitin C</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Protein degradation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>UBC</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NM_021009</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">192 *</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tyrosine 3 monooxygenase activation protein, zeta polypeptide</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Signal transduction</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>YWHAZ</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">NM_003406</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">150 *</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p><sup>1</sup> Non-coding RNA; <sup>2</sup> The numbers with asterisks given for <italic>18s rRNA</italic>, <italic>GAPDH</italic>, <italic>RPL13A</italic>, <italic>SDHA</italic>, <italic>UBC</italic>, and <italic>YWHAZ</italic> do not reflect exact Amplicon sizes. They are indicative of the “context sequence length” [<xref ref-type="bibr" rid="B39-ijms-17-01711">39</xref>] information provided by PrimerDesign Ltd. (Southampton, UK).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="ijms-17-01711-t003" position="float">
<object-id pub-id-type="pii">ijms-17-01711-t003_Table 3</object-id>
<label>Table 3</label>
<caption>
<p>The mean <italic>Cq</italic> values (±SD, <italic>n</italic> = 2–4) of samples studied in phase I.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene Symbol</th>
<th align="center" colspan="3" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Control</th>
<th align="center" colspan="3" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Autism</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Overall SD</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mean</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SD</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">N</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mean</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SD</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">N</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle"><italic>18s</italic>
<italic>rRNA</italic></td>
<td align="center" colspan="1" rowspan="1" valign="middle">16.06</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.78</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">14.58</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.66</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.04</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>ACTB</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">25.87</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.38</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">29.18</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.77</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.34</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>GAPDH</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">26.27</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.29</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">27.01</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.44</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.52</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>RPL13A</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">31.09</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.89</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">32.72</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NA</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.15</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>SDHA</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">33.73</td>
<td align="center" colspan="1" rowspan="1" valign="middle">NA</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">28.93</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.32</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.40</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>TFRC</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">31.14</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.73</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">33.22</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.58</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.47</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>UBC</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">30.22</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.62</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">32.23</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.59</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.42</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>YWHAZ</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">27.54</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.61</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">28.07</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1.11</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.37</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>N, number of samples (from independent individuals) with valid signals; NA, not applicable; SD, standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="ijms-17-01711-t004" position="float">
<object-id pub-id-type="pii">ijms-17-01711-t004_Table 4</object-id>
<label>Table 4</label>
<caption>
<p>Amplification efficiency data for candidate reference genes tested in phase II.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene Symbol</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Slope</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">R<sup>2</sup></th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Efficiency (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>ACTB</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">−3.400</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.981</td>
<td align="center" colspan="1" rowspan="1" valign="middle">96.8</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>GAPDH</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">−3.303</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.989</td>
<td align="center" colspan="1" rowspan="1" valign="middle">100.9</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">
<italic>UBC</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">−3.747</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.974</td>
<td align="center" colspan="1" rowspan="1" valign="middle">84.8</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>YWHAZ</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">−3.398</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.984</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">97.2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Standard curves were used to calculate the reaction efficiency for each gene, using a five-point serial dilution made from pooled stock cDNAs. The amplification efficiency percentage for each gene was calculated using the equation <italic>E</italic> = 10 <sup>(−1/Slope)</sup> − 1 multiplied by 100, where <italic>E</italic> stands for the efficiency and slope is the gradient of the best fit line. R<sup>2</sup>: linear regression coefficient.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>